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General Methods: All reactions were carried out in flame-dried glassware under Ar. The 
solvents were purified by distillation over the drying agents indicated and were transferred under 
Ar: THF, Et2O, 1,4-dioxane (Mg-anthracene), CH2Cl2 (P4O10), MeCN, Et3N, pyridine (CaH2), 
MeOH (Mg), DMF (Desmodur®, dibutyltin dilaurate), hexane, toluene (Na/K). Flash 
chromatography: Merck silica gel 60 (230-400 mesh). NMR: Spectra were recorded on a Bruker 
DPX 300, AV 400, or DMX 600 spectrometer in the solvents indicated; chemical shifts (δ) are 
given in ppm relative to TMS, coupling constants (J) in Hz. The solvent signals were used as 
references and the chemical shifts converted to the TMS scale (CDCl3: δC ≡ 77.0 ppm; residual 
CHCl3 in CDCl3: δH ≡ 7.24 ppm; CD2Cl2: δC ≡ 53.8 ppm; residual CH2Cl2 in CD2Cl2: δH ≡ 5.32 
ppm). IR: Nicolet FT-7199 spectrometer, wavenumbers (ν~ ) in cm−1. MS (EI): Finnigan MAT 
8200 (70 eV), ESI-MS: Finnigan MAT 95, accurate mass determinations: Bruker APEX III FT-
MS (7 T magnet). Melting points: Büchi melting point apparatus B-540 (corrected). Elemental 
analyses: H. Kolbe, Mülheim/Ruhr. Unless stated otherwise, commercially available compounds 
(Fluka, Lancaster, Aldrich) were used as received. 
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Scheme S1. Reagents and conditions: a) MeI, Ag2O, MeCN, 92%; b) (i) DIBAl-H, CH2Cl2, 
−78°C; (ii) MeCOC(=N2)P(O)(OMe)2, K2CO3, MeOH, 70% (over both steps); c) TBSCl, Et3N, 
DMAP cat., CH2Cl2, 90%; d) n-BuLi, MeI, THF, 98%; e) Bu3SnH, (PPh3)2PdCl2 (5 mol%), THF, 
65%; f) TBAF, THF, 93%; g) (i) Dess-Martin periodinane, CH2Cl2, 84%; (ii) Ph3P=CH2, n-BuLi, 
THF, −35°C → RT, 87%. 
 
 
The original route to the northern hemisphere of 2 employed commercial lactone 31 (ee = 96%) 
as the starting material, which was O-methylated and reduced with DIBAl-H to the 
corresponding hemiacetal that allowed for the installation of an alkyne unit by reaction with the 
Ohira-Bestmann reagent (Scheme S1).1 O-Silylation of S-2 and end-capping of the alkyne in S-3 
with a methyl group set the stage for a palladium-catalyzed hydrostannation which converted S-4 
into product S-5 in 65% yield.2 The elaboration of this compound into the required building 
block 36 was readily achieved by cleavage of the silyl ether, oxidation of the resulting primary 




                                                   
1  (a) Ohira, S. Synth. Commun. 1989, 19, 561. (b) Müller, S.; Liepold, B.; Roth, G. J.; Bestmann, H. J. 
Synlett 1996, 521. 
2  Small amounts (10-15%) of the regioisomeric alkenyl-stannane could be separated by flash 
chromatography. Moreover, the corresponding pinacolborane has also been prepared; however, this 
compound failed to undergo productive cross coupling with alkenyl iodide 43. 
3  (a) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155. (b) Meyer, S. D.; Schreiber, S. L. J. Org. 
Chem. 1994, 59, 7549. (c) Boeckman, R. K., Jr.; Shao, P.; Mullins, J. J. Org. Synth. 2000, 77, 141. 
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Scheme S2. Reagents and conditions: a) DIBAl-H, CH2Cl2, −78°C; b) compound S-7, LiHMDS, 
THF, −78°C → −40°C, 75% (over both steps); c) aq. HCl, THF, 91%; d) N-(5-chloro-2-pyridyl)-
bis-(trifluoromethansulfonimide), KHMDS, THF, −78°C → −40°C, 60-65%; e) MeZnCl, 
Pd(PPh3)4 (5 mol%), THF, 50°C, 91%; f) DDQ, CH2Cl2/H2O, 91%; g) Dess-Martin periodinane, 
CH2Cl2; h) CHI3, CrCl2.1.8 THF, THF/1,4-dioxane (1:6), 62% (over two steps). 
 
 
Access was gained by DIBAl-H reduction of the known Roche ester derivative 374 and chain 
extension of the resulting aldehyde with the functionalized phosphonate S-75 furnishing enol 
silane S-8 as a single isomer (Scheme S2). This compound was then converted into the 
corresponding enol triflate 39 of opposite double bond configuration by acid catalyzed hydrolysis 
followed by treatment of S-9 with Comins reagent6 in the presence of KHMDS as the optimal 
base. Triflate 39 could be cross coupled with MeZnCl in the presence of catalytic amounts of 
Pd(PPh3)4.7 The elaboration of the resulting product 40 into the required building block 43 
followed the route described in the Text of the paper. 
 
 
                                                   
4  Heckrodt, T. J.; Mulzer, J. Synthesis 2002, 1857. 
5  (a) Ceccarelli, S. M.; Piarulli, U.; Telser, J.; Gennari, C. Tetrahedron Lett. 2001, 42, 7421. (b) Horne, 
D.; Gaudino, J.; Thompson, W. J. Tetrahedron Lett. 1984, 25, 3529. 
6  Comins, D. L.; Dehghani, A. Tetrahedron Lett. 1992, 33, 6299. 
7  Negishi, E.; Zheng, X.; Tan, Z.; Qian, M.; Hu, Q.; Huang, Z. In Metal-Catalyzed Cross-Coupling 
Reactions; de Meijere, A., Diederich, F., Eds., 2nd ed.; Wiley-VCH: Weinheim, 2004; Vol. 2; pp 815. 
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Scheme S3. Reagents and conditions: a) TBSOTf, 2,6-lutidine, CH2Cl2, 40°C, 91% (R = Ac); 
85% (R = −C(O)C(Me)=CHMe); b) HOAc, THF, 50°C; c) compound 57, EDC, HOBt, N-
methylmorpholine (NMM), CH2Cl2, 0°C → RT, 95% (over steps a)-c)). 
 
Although the degradation pathway of 51 has not been rigorously investigated, model studies were 
undertaken that explain, at least in part, this unexpected behavior (Scheme S-3). Thus, treatment 
of the compound S-10 (R = Ac, tiglinic acid) with TBSOTf/2,6-lutidine converted these 
compounds into a common product S-13 which was obtained in high yield as a mixture of 
diastereomers. It is believed that the conjugated diene efficiently communicates activation of the 
Boc-moiety by the Lewis acid to the seemingly remote substituent residing at C.23 (iejimalide 
numbering). Rearrangement of the π-system with extrusion of the ester then engenders formation 
of the heterocyclic motif.  
In striking contrast to the acetate case, however, the corresponding pivalate S-10 (R = Piv) 
allowed for the clean removal of the Boc-substituent; the bulky ester most likely forces this 
substrate to adopt a conformation in which orbital overlap between the C-O σ-bond and the π-
system of the diene is minimized, thus effectively blocking the decomposition pathway. The 
resulting amine S-14 was coupled to the L-serine derivative 578 under standard conditions to give 
product S-15 in excellent overall yield. The striking difference in the behavior of acetate and 
pivalate clearly features our still limited capacity to properly assess the degree of the homology 
between recorded and projected cases. 
                                                   
8  Hill, D. R.; Hsiao, C.-N.; Kurukulasuriya, R.; Wittenberger, S. J. Org. Lett. 2002, 4, 111. 
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Caspase Assay. The activities of caspases 3 and 7 were quantified by the use of a commercial 
reagent kit (Caspase-Glo 3/7 by Promega) in a coupled enzymatic reaction, which has been used 
for assaying caspase activity and apoptosis in a large variety of applications.9 In this assay the 
luciferin-coupled tetrapeptide DEVD is used as a luminogenic substrate for caspase 3/7. The 
substrate is added to the cells and following caspase cleavage, a new substrate for luciferase 
(amino-luciferin) is released, resulting in the luciferase reaction and the production of light. The 
luminescent signal, produced in the luciferase reaction is proportional to the caspase activity. The 
assay was performed according to the protocol provided by the supplier. Thus, 5 x 103 NIH3T3 
cells were seeded in each well of a white-walled 96-well luminometer plate (Corning Life 
Sciences) and cultured in 100 µL Dulbecco’s Modified Eagle Medium (Invitrogen) supplemented 
with 10 % fetal calf serum (DMEM/FCS) at 37°C and 5 % CO2 in a humidified incubator. On the 
next day, cells were washed with PBS and fresh DMEM/FCS was added. The compounds were 
dissolved as 5 mM stock solution in DMSO. For each final concentration a 10x concentrated 
adding solution (AS) was prepared by diluting the stock solution in DMEM/FCS, e.g. for the 
final concentration 10 µM, 2 µL of the stock solution were added to 98 µL DMEM/FCS to 
prepare the 100 µM AS. Five percent DMSO in DMEM/FCS served as negative control AS. Ten 
microliters of each AS and of the negative control AS were added to the wells and the cells were 
incubated for another 24 h. Cells were washed with PBS and 100 µL of the lysis/test reagent was 
added to each well. The plate was covered with a plate sealer and incubated for 40 min at room 
temperature on a plate shaker. The luminescence was measured in a multi-well plate reader 
(CentroXS LB960, Berthold Technologies). The luminescence of the negative control was set as 
100 % and all other values were referred to this value. All concentrations were tested in 
triplicates. 
Actin Assay. Murine NIH/3T3 fibroblasts (CRL-1658 from ATCC) were cultured at 37°C and 
5% CO2 in Dulbecco's modified Eagle's medium supplemented with 4 mM L-glutamine, 4.5 g/L 
glucose and 10 % bovine calf serum. 2x104 cells were seeded on coverslips in one well of a 24-
well plate. After adapting and attaching over night, the cells were incubated with 1 µM, 5 µM or 
10 µM of the corresponding iejimalide derivative for 18 h. Before and after each fixation or 
staining step the cells were washed three times with TPBS (0.2% Tween20 in phosphate-buffered 
saline). Cells were fixed with 3.7% formalin in PBS. For blocking unspecific epitopes, fixed cells 
were incubated with 1% powdered milk in PBS. Actin filaments were stained for 1h with a 
solution of 77 nM TRITC labelled phalloidin (P1951, Sigma) in TPBS. Cell nuclei were stained 
with DAPI (2-(4-amidinophenyl)-6-indolecarbamidine dihydrochloride, D9542, Sigma). Cells 
were visualized and photographed with a Zeiss Axiophot fluorescence microscope. 
                                                   
9  (a) Feng, Y.; Ariza, M. E.; Goulet, A. C.; Shi, J.; Nelson, M. A. Biochem. J. 2005 392, 65. (b) Liu, 
D.; Li, C.; Chen, Y.; Burnett, C.; Liu, X.Y.; Downs, S.; Collins, R. D.; Hawiger, J. J. Biol. Chem. 
2004, 279, 48434. (c) Notebaert, S.; Duchateau, L.; Meyer, E. Vet. Res. 2005, 36, 229. (d) Ren, Y. G.; 
Wagner, K. W.; Knee, D. A.; Aza-Blanc, P.; Nasoff, M.; Deveraux, Q. L. Mol. Biol. Cell 2004, 15, 
5064. 
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Building Blocks: Preparation of Boronate 19 
Compound 10. Bis(trimethylsilyl)acetylene (25.3 mL, 0.111 mol) was added to a solution of acid 
chloride 9 (12.3 mL, 0.111 mol) in anhydrous CH2Cl2 (140 mL). The 
mixture was cooled to 0°C before AlCl3 (14.9 g, 0.111 mol) was added 
in small portions over 5 min. The reaction mixture was then stirred at 
0°C for 10 min and at 20ºC for 1 h. For work-up, the mixture was 
poured onto aq. HCl (1 M) at 0°C, the aqueous phase was extracted with diethyl ether, the 
combined organic layers were washed with brine, dried over Na2SO4 and evaporated (because of 
volatility of the product, the heating bath of the rotary evaporator was set to 20°C and the applied 
vacuum was kept at ≥ 30 mbar). The residue was purified by Kugelrohr distillation to yield 10 as 
a colorless oil (16.64 g, 83%). 1H NMR (400 MHz, CDCl3): δ = 5.81 (tdd, J = 16.8, 10.2, 6.4 Hz, 
1H), 5.04 (m, 2H), 2.66 (t, J = 7.4 Hz, 2H), 2.42 (m, 2H), 0.25 (s, 9H); 13C NMR (100 MHz, 
CDCl3): δ = 186.9, 136.3, 115.7, 101.9, 98.0, 44.3, 27.8, 0.8; IR (film): 
O
SiMe3
υ~  = 3081, 2963, 2902, 
2152, 1680, 1643, 1439, 1409, 1356, 1253, 1227, 1115, 1094, 1031, 998, 968, 915, 865, 847, 
762, 704, 626, 589 cm-1; HRMS (EI/FE): m/z: calcd for C10H16OSi: 180.097041 [M+]; found: 
180.097232; elemental analysis calcd (%) for C10H16OSi: C 66.61, H 8.94; found: C 66.46, H 
8.98. 
Compound 12. A flame-dried Schlenk flask was charged with ketone 10 (8.37 g, 0.0446 mol) 
and degassed isopropanol (350 mL). The resulting solution was purged 
with Ar for 1.5 h before the ruthenium complex 11 was added as a solid 
(0.175 g, 0.0292 mol). The resulting mixture was again purged with Ar 
before it was stirred for 19 h at 20ºC. For work up, the mixture was 
transferred into a round-bottomed flask (with diethyl ether), the 
solvents were evaporated under reduced pressure (due to volatility of the product, the heating 
bath of the rotary evaporator was set to 20°C and the applied vacuum was kept at ≥ 30 mbar), and 
the crude product was purified by flash chromatography (hexanes/ethylacetate, 50:1→30:1) to 
give alcohol 12 as a colorless oil (8.31 g, 98 %). [ ]20Dα = +6 (c = 0.43, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 5.84 (tdd, J = 6.7, 10.2, 16.9 Hz, 1H), 5.03 (m, 2H), 4.38 (t, J = 6.5 Hz, 1H), 
2.23 (m, 2H), 1.77-1.83 (m, 2H), 0.18 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 137.7, 115.3, 
106.5, 89.7, 62.4, 36.8, 29.4, -0.1; IR (film): υ~  = 3336, 3079, 2959, 2900, 2863, 2173, 1642, 
1440, 1415, 1332, 1251, 1121, 1068, 1046, 1016, 955, 913, 895, 844, 761, 700, 648, 612, 555, 
489 cm-1; MS (EI): m/z: 167 (9), 149 (8), 140 (17), 127 (15), 125 (12), 99 (45), 92 (10), 91 (32), 
75 (100), 73 (73), 61 (12), 45 (21), 43 (13), 41 (13); elemental analysis calcd (%) for C10H18OSi: 
C 65.87, H 9.95; found: C 65.72, H 9.84.  
Compound 13. n-BuLi (10.6 mL, 1.6 M in hexanes) was added dropwise over a period of 10 min 
via a syringe pump to a solution of compound 12 (3.10 g, 0.017 mol) in 
THF (60 mL) at −78°C. Once the addition was complete, stirring was 
continued for 10 min at −78°C before MeI (8.5 mL, 0.137 mol) was 
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−25°C, at which point DMSO (2.5 mL) was slowly introduced, causing the formation of a white 
precipitate. After stirring for 1h at that temperature, the cooling bath was removed and stirring 
continued at 20ºC for 21 h. The reaction mixture was poured to a 1:1 mixture of ice and aq. sat. 
NH4Cl, the organic phase was extracted with Et2O, the organic layers were combined, washed 
with water and brine, dried over Na2SO4, and evaporated (due to high volatility of the product, 
the heating bath of the rotary evaporator bath was set to 20°C and pressure kept at ≥ 35 mbar) to 
give product 13 as pale yellow oil (3.30 g, 99%, ee = 98.8 %). The crude product is pure enough 
for immediate use in the next step. [ ]20Dα = −37.9 (c = 0.61, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 5.83 (tdd, J = 6.7, 10.2, 16.9 Hz, 1H), 5.00 (m, 2H), 3.93 (t, J = 6.6 Hz, 1H), 3.36 (s, 
3H), 2.19 (m, 2H), 1.67-1.82 (m, 2H), 0.18 (s, 9H); 13C NMR (MHz, CDCl3): δ = 138.4, 115.1, 
105.0, 90.9, 71.3, 56.4, 35.1, 29.8, 0.0; IR (film): υ~  = 3079, 2958, 2927, 2854, 2822, 2170, 1642, 
1465, 1450, 1415, 1335, 1251, 1160, 1107, 1011, 994, 922, 844, 761, 700, 652, 612 cm-1; HRMS 
(CI/FE i-butane): m/z: calcd for C11H20OSi+H: 197.135980 [M++H]; found: 197.136170; 
elemental analysis calcd (%) for C11H20OSi: C 67.28, H 10.27; found: C 67.06, H 10.18. 
Compound 14. To a solution of compound 13 (1.29 g, 0.0066 mol) in 1,4-dioxane/water (50/16 
mL) at 20ºC were sequentially added 2,6-lutidine (1.5 mL, 0.0134 
mol), OsO4 (1.6 mL, 0.00013 mol, 2.5 % w/w in t-BuOH) and NaIO4 
(5.65 g, 0.0264 mol). The resulting heterogeneous mixture was stirred 
for 3 h before it was diluted with water, the aqueous phase was 
extracted with tert-butyl methyl ether and EtOAc, the combined 
organic layers were washed with HCl (1 M) and brine, dried over MgSO4, and carefully 
evaporated (due to high volatility of the product, the heating bath of the rotary evaporator bath 
was set to 20°C and pressure kept at ≥ 35 mbar) The crude product was purified by flash 
chromatography (pentanes/Et2O, 15:1) to give product 14 as a colorless oil (995 mg, 76%). 
= −82.1 (c = 0.51, CH[ ]20Dα 2Cl2); 1H NMR (400 MHz, CDCl3): δ = 9.79 (t, J = 1.5 Hz, 1H), 4.01 
(t, J = 6.1 Hz, 1H), 3.38 (s, 3H), 2.61 (m, 2H), 2.04 (dt, J = 7.2, 6.2 Hz, 2H), 0.18 (s, 9H); 13C 
NMR (100 MHz, CDCl3): δ = 201.8, 103.5, 91.7, 70.5, 56.6, 39.7, 28.2, 0.1; IR (film): υ~  = 2960, 
2941, 2900, 2824, 2724, 2170, 1727, 1466, 1440, 1412, 1390, 1334, 1251, 1201, 1178, 1114, 
1091, 1017, 989, 958, 919, 844, 761, 700, 668, 612 cm-1; HRMS (CI/FE i-butane): m/z: calcd for 
C10H18O2Si+H: 199.115434 [M++H]; found: 199.115280; elemental analysis calcd (%) for 




Compound 15. A Schlenk flask was charged with (CF3CH2O)2P(O)CH(Me)COOMe (1.63 g, 
0.00489 mol), 18-crown-6 (0.860 g, 0.00325 mol) and toluene (27 
mL). A solution of KHMDS (9.25 mL, 0.5 M in toluene) was added 
dropwise at 0°C and the resulting mixture was stirred at 0°C for 45 
min before it was cooled to −20°C. A solution of aldehyde 14 
(0.936 g, 0.00472 mol) in toluene (16 mL) was added over 15 min 
and stirring continued for 10 min at that temperature before the mixture was allowed to warm to 
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aqueous layer was extracted with tert-butyl methyl ether, the combined organic phases were dried 
over Na2SO4 and evaporated, and the crude product purified by flash chromatography 
(hexanes/ethyl acetate, 20:1) to give product 15 as a colorless oil (1.10 g, 87%, ee = 95.5%). 
= −18.1 (c = 0.44, CH[ ]20Dα 2Cl2); 1H NMR (400 MHz, CDCl3): δ = 5.95 (qt, J = 7.5, 1.5 Hz, 1H), 
3.94 (t, J = 6.5 Hz, 1H), 3.74 (s, 3H), 3.39 (s, 3H), 2.59 (m, 2H), 1.90 (dd, J = 2.7, 1.3 Hz, 3H), 
1.80 (m, 2H), 0.18 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 168.5, 141.9, 127.7, 104.3, 90.7, 
71.1, 56.4, 51.3, 35.2, 25.7, 20.7, 0.0; IR (film): υ~  = 2955, 2901, 2843, 2822, 2169, 1720, 1648, 
1456, 1435, 1367, 1334, 1251, 1227, 1198, 1175, 1134, 1108, 1074, 1009, 950, 844, 761, 700, 
672, 616 cm-1; HRMS (ESI): m/z: calcd for C14H24O3Si+Na: 291.13916 [M++Na]; found: 
291.13924; elemental analysis calcd (%) for C14H24O3Si: C 62.64, H 9.01; found: C 62.76, H 
8.89. 
Compound 16. A solution of DIBAl-H (7.0 mL, 1.0 M in hexanes) was slowly added to a 
solution of compound 15 (745 mg, 0.00277 mol) in CH2Cl2 (30 
mL) at −78ºC and the resulting mixture was stirred at that 
temperature for 1 h. For work-up, the reaction was quenched with 
EtOAc (80 mL) and the solution was slowly warmed to 0ºC. A sat. 
aq. solution of Rochelle’s salt was added (40 mL) and the mixture 
was stirred at 40ºC for 45 min to ensure a clean separation of the phases. The aqueous layer was 
extracted with EtOAc, and the combined organic phases were dried over MgSO4 and evaporated, 
affording alcohol 15b which is pure enough for immediate use in the next step (656 mg, 99%). 
= −17.8 (c = 1.7, CH[ ]20Dα 2Cl2); 1H NMR (400 MHz, CDCl3): δ = 5.25 (t, J = 7.6 Hz, 1H), 4.10 
(s, 2H), 3.93 (t, J = 6.6 Hz, 1H), 3.37 (s, 3H), 2.20 (q, J = 7.2 Hz, 2H), 1.79 (d, J = 1.2 Hz, 3H), 
1.80-1.67 (m, 2H), 0.00 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 135.8, 127.0, 104.3, 91.2, 
70.6, 61.5, 56.1, 35.2, 23.4, 22.0, 0.0; IR (film): υ~  = 2360, 2358, 2550, 2341, 667 cm-1; HRMS 
(ESI): m/z: calcd for C13H24O2Si+Na: 241.162142 [M++ Na], found: 241.162386; elemental 





MnO2 (2.20 g, 0.0216 mol) was added in portions over 5 min to a 
solution of crude 15b (260 mg, 0.00108 mol) in CH2Cl2 at 20ºC. 
The mixture was stirred for 13 h before it was filtered through a pad 
of Celite which was carefully rinsed with CH2Cl2. Evaporation of 
the combined filtrates gave aldehyde 16 as a colorless oil which was 
used in the next step without further purification (246 mg, 96%). [ ]20Dα = −8.3 (c = 1.1, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 9.98 (s, 1H), 6.51 (td, J = 8.3, 1.4 Hz, 1H), 3.95 (t, J = 6.3 Hz, 
1H), 3.88 (s, 3H), 2.75 (m, 2H), 1.92-1.82 (m, 2H), 1.78 (d, J = 1.4 Hz, 3H), 0.18 (s, 9H); 13C 
NMR (100 MHz, CDCl3): δ = 191.2, 148.0, 136.7, 103.5, 91.6, 70.4, 56.5, 35.0, 22.4, 16.5, −0.1; 
IR (film): υ~  = 2960, 2901, 2824, 2170, 1723, 1682, 1450, 1381, 1334, 1251, 1108, 844, 761, 702 





   
S-9 
Compound 17. A solution of n-BuLi (0.7 mL, 1.58 M in hexanes) was added dropwise to a 
suspension of methyltriphenylphosphonium bromide (0.405 g, 
0.00113 mol) in THF (3 mL) at −78ºC. The resulting mixture was 
allowed to reach ambient temperature. After stirring for 30 min, the 
orange solution was again cooled to −78ºC before a solution of 
aldehyde 16 (246 mg, 0.00103 mol) in THF (7 mL) was slowly 
added. The reaction was warmed to ambient temperature over the course of 1 h before being 
quenched with aq. sat. NH4Cl. The aqueous phase was extracted with EtOAc, the combined 
organic extracts were dried over MgSO4 and evaporated, and the crude product was adsorbed on 
Celite and purified by flash chromatography (hexanes/EtOAc, 100:1) to give product 17 as a 
colorless oil (243 mg, quant.). [ ] = −1.2 (c = 0.5, CH20Dα 2Cl2); 1H NMR (400 MHz, CDCl3): δ = 
6.80 (ddd, J = 17.3, 10.8, 0.8 Hz, 1H), 5.37 (t, J = 7.7 Hz, 1H), 5.20 (dd, J = 17.3, 0.7 Hz, 1H), 
5.08 (dt, J = 10.8, 1.6 Hz, 1H), 3.91 (t, J = 6.5 Hz, 1H), 3.38 (s, 3H), 2.33 (q, J = 7.5 Hz, 2H), 
1.81 (d, J = 1.1 Hz, 3H), 1.80-1.60 (m, 2H), 0.18 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 
133.6, 133.3, 129.8, 113.7, 104.5, 90.8, 70.9, 56.5, 35.5, 23.1, 19.8, 0.0; IR (film): υ~  = 3090, 
2960, 2941, 2900, 2821, 2169, 1645, 1596, 1441, 1380, 1251, 1108, 1010, 902, 843, 760 cm-1; 
HRMS (ESI): m/z: calcd for C14H24OSi+Na: 236.159456 [M++Na]; found: 236.159647. 
OMe
SiMe3
Compound 18. K2CO3 (426 mg, 0.00309 mol) was added in small portions over 5 min to a 
solution of compound 17 (243 mg, 0.00103 mol) in MeOH (20 mL). The 
resulting mixture was stirred for 3 h before it was filtered through a pad of 
Celite. The filtrate was evaporated and the crude product purified by flash 
chromatography (pentanes/Et2O, 100:1) to give product 18 as a colorless oil 
(139 mg, 83%). Upon evaporation of the solvents, the heating bath of the rotary evaporator bath 
was set to 20°C and the pressure kept at ≥ 30 mbar. [ ]20Dα = −17 (c = 0.75, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 6.79 (ddd, J = 17.3, 10.8, 0.8 Hz, 1H), 5.37 (t, J = 7.6 Hz, 1H), 5.37 (t, J = 7.6 
Hz, 1H), 5.20 (dd, J = 17.3, 0.7 Hz, 1H), 5.09 (dt, J = 10.8, 1.6 Hz, 1H), 3.91 (td, J = 6.6, 2.0 Hz, 
1H), 3.40 (s, 3H), 2.45 (d, J = 2.0 Hz, 1H), 2.40-2.28 (m, 2H), 1.82 (d, J = 1.1 Hz, 3H), 1.87-1.71 
(m, 2H); 13C NMR (100 MHz, CDCl3): δ = 133.5, 133.3, 129.5, 113.7, 82.6, 73.8, 70.2, 56.5, 
35.5, 23.0, 19.8; IR (film): υ~  = 3297, 2939, 2856, 2824, 1644, 1597, 1462, 1441, 1382, 1355, 
1260, 1107, 920, 905, 638 cm-1; HRMS (ESI): m/z: calcd for C11H16O+Na: 164.119954 [M++Na]; 
found: 164.120114. 
OMe
Compound 19. Pinacol borane (159 µL, 1.02 mmol) and 9-BBN (10.4 mg, 0.085 mmol) were 
added to a solution of compound 18 (139 mg, 0.85 mmol) in THF 
(1.7 mL) and the resulting mixture was stirred for 60 h at 45ºC. 
For work up, the reaction was quenched with aq. sat. NH4Cl, the 
aqueous phase was extracted with EtOAc, the combined organic 
layers were dried over MgSO4 and evaporated, and the crude 
product purified by flash chromatography (hexanes/EtOAc, 100:1→20:1) to give product 19 as a 
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NMR (400 MHz, CDCl3): δ = 6.77 (ddd, J = 17.4, 10.9, 0.8 Hz, 1H), 6.42 (dd, J = 18.1, 6.7 Hz, 
1H), 5.69 (dd, J = 18.1, 1.1 Hz, 1H), 5.35 (t, J = 7.5 Hz, 1H), 5.18 (dd, J = 17.4, 0.9 Hz, 1H), 
5.07 (dt, J = 10.9, 1.6 Hz, 1H), 3.59-3.54 (m, 1H), 3.27 (s, 3H), 2.32-2.16 (m, 2H), 1.81 (d, J = 
1.1 Hz, 3H), 1.66-1.49 (m, 2H), 1.28 (s, 12H); 13C NMR (100 MHz, CDCl3): δ = 153.0, 133.7, 
132.8, 130.4, 113.4, 83.3, 82.8, 56.8, 35.0, 24.8 (2C), 23.2, 19.8; the C-atom directly bonded to 
boron could not be detected because of line broadening caused by C,B-coupling; IR (film): υ~  = 
3089, 2978, 2930, 1641, 1596, 1366, 1335, 1146, 990, 970, 849 cm-1; HRMS (ESI): m/z: calcd 
for BC17H29O3+Na: 315.210315 [M++Na]; found: 315.210193. 
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Building Blocks: Preparation of Vinyl Iodide 30 
 
Compound 26. Pd(OAc)2 (11 mg, 0.0489 mmol) and PPh3 (13 mg, 0.0495 mmol) were added to 
a solution of mesylate 25a (570 mg, 1.87 mmol)10 in THF 
(15 mL) at −78°C. After stirring for 5 min, a solution of 
aldehyde 24 (231 mg, 0.965 mmol)11 in THF (15 mL) was 
introduced, followed by the dropwise addition of a solution 
of ZnEt2 (3.0 mL, 1 M in hexane). After stirring for 30 min, 
the mixture was warmed to −20°C over a period of 30 min 
and stirred overnight at that temperature. The reaction was quenched with aq. sat. NH4Cl, the 
aqueous phase was extracted with tert-butyl methyl ether, the combined organic layers were 
washed with brine, dried over Na2SO4, and evaporated, and the crude product (d.r. = 7.5:1, NMR) 
was purified by flash chromatography (hexanes/EtOAc, 10:1→4:1) to give product 26 as a 
colorless oil (311 mg, 72%). [ ] = +56.3 (c = 1.1, CH20Dα 2Cl2); 1H NMR (400 MHz, CDCl3): δ = 
6.24 (d, J = 11.1 Hz, 1H), 6.12 (d, J = 11.1 Hz, 1H), 4.58 (bs, 1H), 3.85 (d, J = 7.2 Hz, 1H), 3.74 
(d, J = 4.9 Hz, 2H), 2.74 (m, 1H), 2.38 (bs, 1H), 1.75 (s, 3H), 1.73 (s, 3H), 1.45 (s, 9H), 1.13 (d, J 
= 7.0 Hz, 3H), 1.05 (m, 21H); 13C NMR (100 MHz, CDCl3): δ = 156.1, 136.1, 135.6, 123.3, 
120.9, 109.7, 83.8, 81.0, 79.5, 48.4, 33.1, 28.5, 18.7, 18.0, 15.0, 12.1, 11.3; IR (film): υ~  = 3358, 
2941, 2865, 2164, 1696, 1506, 1462, 1388, 1247, 1168, 1075, 1017, 996, 882, 850, 675 cm-1; 
HRMS (ESI): m/z: calcd for C26H47NO3Si+Na: 472.321738 [M++Na]; found: 472.322127; 




Compound 27. A solution of TBAF (0.09 mL, 1 M in THF) was added to a solution of 
compound 26 (226 mg, 0.502 mmol) in THF (8 mL) at 0°C. After 
stirring for 60 min, the reaction was quenched with H2O, the 
aqueous phase was extracted with tert-butyl methyl ether, and the 
combined organic layers were washed with brine, dried over 
Na2SO4, and evaporated. Purification of the residue by flash 
chromatography (hexanes/EtOAc, 2:1) gave product 27 as a colorless oil (139 mg, 94%). [ ]20Dα = 
+48.3 (c = 1.05, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 6.23 (d, J = 11.1 Hz, 1H), 6.11 (d, J = 
11.1 Hz, 1H), 4.62 (bs, 1H), 3.90 (dd, J = 7.6, 3.4 Hz, 1H), 3.73 (d, J = 5.4 Hz, 2H), 2.80-2.60 
(m, 1H), 2.24 (d, J = 3.4 Hz, 1H), 2.16 (d, J = 2.4 Hz, 1H), 1.75 (s, 3H), 1.72 (s, 3H), 1.44 (s, 
9H), 1.10 (d, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 155.6, 135.5, 123.1, 120.1, 85.4, 
80.5, 70.5, 47.8, 30.9, 28.0, 17.2, 14.5, 11.4; IR (film): υ~  = 3309, 2977, 2934, 1691, 1507, 1366, 




                                                   
10  Marshall, J. A.; Eidam, P.; Eidam, H. S. J. Org. Chem. 2006, 71, 4840. 
11  Cottard, M.; Kann, N.; Rein, T.; Akermark, B.; Helquist, P. Tetrahedron Lett. 1995, 36, 3115. 
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Compound 28. Pivaloyl chloride (0.29 mL, 0.00235 mol) was added dropwise to a solution of 
compound 27 (460 mg, 0.00157 mol) in pyridine (4 mL) at 0ºC. 
The mixture was stirred for 48 h at ambient temperature before the 
reaction was diluted with EtOAc and quenched with aq. HCl (1 M; 
saturated with NaCl). The aqueous phase was extracted with 
EtOAc, the combined organic layers were washed with brine, dried 
over MgSO4 and adsorbed on silica. Purification by flash chromatography (hexanes/EtOAc, 25:1) 
gave product 28 as a yellow oil (416 mg, 76%). [ ]20Dα = +17.7 (c = 1.19, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 6.27 (d, J = 11.3 Hz, 1H), 6.08 (d, J = 11.3 Hz, 1H), 5.07 (d, J = 7.8 Hz, 1H), 
4.63 (bs, 1H), 3.72 (d, J = 5.3 Hz, 2H), 2.79 (m, 1H), 2.01 (d, J = 2.4 Hz, 1H), 1.73 (s, 3H), 1.71 
(s, 3H), 1.43 (s, 9H), 1.21 (s, 9H), 1.10 (d, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 
177.3, 156.1, 136.5, 132.8, 124.6, 85.3, 80.8, 79.5, 69.7, 48.3, 39.1, 29.5, 28.5, 27.3, 17.6, 15.1, 
12.6; IR (film): υ~  = 3314, 2976, 2933, 1712 (br), 1513, 1480, 1455, 1392, 1366, 1278, 1248, 
1153, 1060, 1010, 969, 936, 874 cm-1; HRMS (ESI): m/z: calcd for C22H35NO4+Na: 400.245951 
[M++Na]; found: 400.245829; elemental analysis calcd (%) for C22H35NO4: C 69.99, H 9.34; 
found: C 69.95, H 9.60. 
NHBoc
PivO
Compound 29. A solution of compound 28 (75.0 mg, 0.20 mmol) in THF (1.7 mL) was added 
dropwise to a suspension of Schwartz reagent (61 mg, 0.24 mmol) 
in THF (1 mL). After stirring for 1 h in the dark, the mixture was 
cooled to 0ºC before a solution of I2 (76 mg, 0.30 mmol) in THF 
(1.5 mL) was added dropwise until a pale yellow color persisted. 
After stirring for 5 min, the reaction was quenched with aq. sat. 
Na2S2O3 and diluted with tert-butyl methyl ether, and stirring was 
continued for another 10 min. The aqueous phase was then extracted with tert-butyl methyl ether, 
the combined organic layers were dried over MgSO4 and evaporated, and the residue was purified 
by flash chromatography (hexanes/EtOAc, 20:1) to give product 29 as a yellow oil (85 mg, 
85%). = +3 (c = 0.28, CH[ ]20Dα 2Cl2); 1H NMR (400 MHz, CDCl3): δ = 6.38 (dd, J = 14.4, 8.8 Hz, 
1H), 6.20 (d, J = 11.0 Hz, 1H), 6.08 (d, J = 11.0 Hz, 1H), 6.06 (dd, J = 14.4, 0.7 Hz, 1H), 4.95 (d, 
J = 8.4 Hz, 1H), 4.59 (brs, 1H), 3.73 (d, J = 5.4 Hz, 2H), 2.59-2.50 (m, 1H), 1.75 (s, 3H), 1.70 (s, 
3H), 1.50 (s, 9H), 1.09 (s, 9H), 0.93 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 177.1, 
155.9, 147.5, 136.2, 132.8, 124.4, 120.2, 81.1, 75.9, 48.2, 43.3, 38.9, 28.4, 27.2, 16.3, 15.0, 12.4; 
one carbon signal is missing due to overlapping; IR (film): υ~  = 3380, 2975, 1717 (br), 1509, 
1479, 1366, 1279, 1161, 963 cm-1; HRMS (ESI): m/z: calcd for C22H36INO4+Na: 528.157591 
[M++Na]; found: 528.158125; elemental analysis calcd (%) for C22H36INO4: C 52.37, H 6.87; 




Compound 30. A solution of DIBAl-H (0.62 mL, 1 M in hexanes) was added dropwise to a 
solution of compound 29 (121 mg, 0.24 mmol) in CH2Cl2 (2.1 mL) at −78ºC. After stirring for 1 
h, the reaction was quenched with EtOAc and warmed to ambient temperature before a saturated 
aqueous solution of Rochelle´s salt was introduced and stirring continued at 45ºC for 30 min. The 
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two phases were separated, the aqueous layer was extracted with EtOAc, the combined organic 
extracts dried over MgSO4 and evaporated, and the crude product purified by flash 
chromatography (hexanes/EtOAc, 10:1→4:1) to give product 30 as 
a colorless oil (94 mg, 87%). [ ]20Dα = +59 (c = 0.1, CH2Cl2); 1H 
NMR (400 MHz, CD2Cl2): δ = 6.53 (dd, J = 14.4, 8.4 Hz, 1H), 
6.20-6.10 (m, 3H), 4.61-4.57 (brs, 1H), 3.80 (d, J = 7.9 Hz, 2H), 
3.75-3.73 (m, 2H), 2.46-2.36 (m, 1H), 1.76 (s, 3H), 1.73 (s, 3H), 
1.46 (s, 9H), 0.91 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, 
CD2Cl2): δ = 156.2, 149.2, 137.4, 136.3, 123.4, 120.5, 81.4, 75.9, 48.4, 44.9, 28.5, 16.4, 15.0, 
11.9; one carbon signal is missing due to overlapping; IR (film): υ~  = 3367, 2976, 1694 (br), 
1512, 1366, 1249, 1168, 1008 cm-1; HRMS (ESI): m/z: calcd for C17H28INO3+Na: 444.1010 





Optimized Synthesis of Stannane 36 
 
Compound 35. MnO2 (4.9 g, 56 mmol) was added to a solution of compound 33 (774 mg, 2.14 
mmol)12 in CH2Cl2 (30 mL) and the resulting mixture stirred for 20 h. After filtration through a 
pad of Celite and evaporation of the filtrate, aldehyde 34 was obtained in sufficient quality for 
immediate use in the subsequent allylation (730 mg, 95% crude yield). The recorded 
spectroscopic data were identical to those reported in literature.13
A solution of allylmagnesium bromide (2.85 mL, 1 M in Et2O) was added 
dropwise over 30 min to a solution of (−)-Ipc2BOMe (930 mg, 2.94 mmol) 
in Et2O (2 mL) at 0°C. The resulting mixture was stirred for 30 min at 0°C 
before it was allowed to reach ambient temperature over the course of 1 h. 
The precipitated salts were filtered off under Ar through a pad of dried Celite and the filtrate was 
cooled to −78°C. A solution of crude aldehyde 34 (730 mg, 2.03 mmol) in Et2O (2 mL) was 
added dropwise over 30 min and the resulting mixture stirred at that temperature for 2 h. The 
mixture was then allowed to reach ambient temperature over the course of 1 h before it was 
quenched with a mixture of H2O2 (1.5 mL, 30% w/w) and aq. NaOH (3.6 mL, 3 M). The mixture 
was refluxed for 1 h and then stirred at ambient temperature for 15 h before being diluted with 
EtOAc and extracted with brine. The organic layers were dried over Na2SO4 and evaporated, and 
the residue was purified by flash chromatography (hexanes/EtOAc, 20:1) to give product 35 as a 
colorless oil (614 mg, 75%, ee = 93%). [ ]20Dα = −12 (c = 0.23, CHCl3); 1H NMR (400 MHz, 
CDCl3): δ = 5.80 (m, 1H), 5.54 (m, 1H), 5.10 (m, 2H), 4.59 (m, 1H), 2.28 (m, 2H), 1.89 (s, 3H), 
1.47 (m, 6H), 1.31 (m, 6H), 0.89 (m, 15H); 13C NMR (100 MHz, CDCl3): δ = 142.5, 141.6, 
134.4, 117.8, 66.5, 41.9, 29.1, 27.3, 19.6, 13.6, 9.1; IR (film): υ~  = 3321, 2956, 2923, 2871, 2853, 
HO SnBu3
                                                   
12  Betzer, J.-F.; Delaloge, F.; Muller, B.; Pancrazi, A.; Prunet, J. J. Org. Chem. 1997, 62, 7768. 
13  Dominguez, B.; Pazos, Y.; De Lera, A. R. J. Org. Chem. 2000, 65, 5917. 
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1641, 1463, 1376, 1339, 1292, 1070, 1018, 998, 911, 864, 663 cm-1; HRMS (ESI): m/z: calcd for 
C19H38OSn+Na: 425.183615 [M++Na]; found: 425.183295; elemental analysis calcd (%) for 
C19H38OSn: C 56.88, H 9.55; found: C 56.68, H 9.56. 
Compound 36. A solution of compound 35 (530 mg, 1.32 mmol) in CH2Cl2 (5 mL) was added 
dropwise over 15 min to a mixture of Meerwein salt (260 mg, 1.75 mmol) 
and proton sponge (434 mg, 2.02 mmol) in CH2Cl2 (10 mL) at 0°C. After 
warming to ambient temperature within 1 h, the suspension was stirred for 
14 h. For work up, the mixture was filtered through a pad of Celite, the 
filtrate was diluted with EtOAc and extracted with brine, the organic 
phases were dried over Na2SO4 and evaporated, and the residue purified by flash chromatography 




3); 1H NMR (400 MHz, CDCl3): δ = 5.80 (m, 1H), 5.37 (dd, J = 8.6, 1.8 Hz, 1H), 5.05 (m, 
2H), 4.14 (m, 1H), 3.27 (s, 3H), 2.35 (m, 1H), 2.22 (m, 1H), 1.88 (d, J = 1.8 Hz, 3H), 1.49 (m, 
6H), 1.30 (m, 6H), 0.88 (m, 15H); 13C NMR (100 MHz, CDCl3): δ = 142.5, 140.5, 134.4, 116.3, 
75.1, 55.5, 28.8, 26.9, 19.4, 13.3, 13.3, 7.2; IR (film): υ~  = 2956, 2924, 1641, 1463, 1098 cm-1; 
HRMS (ESI): m/z: calcd for C20H40OSn+Na: 439.199261 [M++Na]; found: 439.199124. 
MeO SnBu3
 
Building Blocks: ‘Second Generation’ Synthesis of Compound 43 
 
Compound 40. A solution of DIBAl-H (5.5 mL, 1 M in CH2Cl2) was added dropwise at −78ºC to 
a solution of compound 37 (1.2 g, 5 mmol) in CH2Cl2 (25 mL) and the resulting mixture was 
stirred for 30 min at that temperature before the reaction was quenched with EtOAc (6 mL).  
In a separated flask, phosphonate 44 (1.32 mL, 6.0 mmol) was added 
dropwise to a solution of LiHMDS (1.1 g, 6.5 mmol) in THF (25 mL) 
at −78°C and the mixture was stirred for 20 min before the solution 
containing the crude aldehyde 38 was slowly introduced. The resulting mixture was warmed to 
−40ºC and stirred for 17 h. For work up, the reaction was quenched with aq. sat. NH4Cl, the 
mixture was stirred at 40ºC, an aq. solution of Rochelle´s salt (1 M) was added and stirring 
continued for 1 h until a clean separation of the phases was reached. The aqueous layer was 
extracted with EtOAc, the combined organic extracts were washed with brine, dried over MgSO4 
and evaporated to give the crude product as a 2.8:1 (Z/E mixture) which was used in the next step 
without further purification.  
PMBO
COOEt
AIBN (164 mg, 1 mmol) and diphenyldisulfide (546 mg, 2.5 mmol) were successively added to a 
solution of the crude enoate 45 (5 mmol) in THF (17 mL) and the resulting mixture was stirred at 
reflux for 96 h until GC showed complete isomerization to the desired E-configurated isomer 40. 
For work up, the mixture was evaporated and the residue purified by flash chromatography to 
give product 40 as a colorless oil (1.12 g, 77% over 3 steps). [ ]20Dα = +8 (c = 2.8, CH2Cl2); 1H 
NMR (400 MHz, CD2Cl2): δ = 7.24 (ddd, J = 8.7, 2.8, 2.1 Hz, 2H), 6.87 (ddd, J = 8.7, 2.8, 2.1 
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Hz, 2H), 6.56 (dq, J = 9.7, 1.4 Hz, 1H), 4.41 (s, 2H), 4.15 (q, J = 7.1 Hz, 2H), 3.79 (s, 3H), 3.35 
(d, J = 6.7 Hz, 2H), 2.88-2.77 (m, 1H), 1.84 (d, J = 1.4 Hz, 3H), 1.28 (t, J = 7.1 Hz, 3H), 1.01 (d, 
J = 6.7 Hz, 3H); 13C NMR (75 MHz, CD2Cl2): δ = 168.7, 160.0, 145.0, 131.4, 129.9, 128.8, 
114.4, 74.9, 73.4, 61.1, 55.9, 34.6, 17.1, 14.8, 13.1; IR (film): υ~  = 2961, 2932, 2856, 1708, 1650, 
1613, 1586, 1513, 1463, 1366, 1301, 1246, 1172, 1146, 1085, 1035, 820, 749 cm-1; HRMS (ESI): 
m/z: calcd for C17H24O4+Na: 315.1566 [M++Na]; found: 315.1567. 
Compound 40b. DDQ (85 mg, 0.37 mmol) was added in one portion to a solution of compound 
40 (100 mg, 0.34 mmol) in CH2Cl2 (2 mL) and H2O (0.45 mL). After 
stirring for 1 h, the mixture was diluted with CH2Cl2 and successively 
washed with aq. sat. NaHCO3 (2 x) and brine, the organic layer was dried 
over MgSO4 and evaporated, and the residue purified by flash 
chromatography (hexanes/EtOAc, 8:1→4:1) to give product 40b as a colorless oil (49 mg, 83%). 
= −25.0 (c = 0.3, CH[ ]20Dα 2Cl2); 1H NMR (400 MHz, CDCl3): δ = 6.55 (dd, J = 9.9, 1.4 Hz, 1H), 
4.19 (q, J = 7.1 Hz, 2H), 3.60-3.45 (m, 2H), 2.82-2.70 (m, 1H), 1.89 (d, J = 1.4 Hz, 3H), 1.40 (br, 
1H), 1.30 (t, J = 7.1 Hz, 3H), 1.03 (d, J = 6.7 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ = 167.7, 




υ~  = 3440, 2962, 2932, 2874, 1707, 
1649, 1448, 1368, 1259, 1128, 1032, 748 cm-1; HRMS (ESI): m/z: calcd for C9H16O3+H: 
173.1178 [M++H]; found: 173.1176. 
Compound 43. Dess-Martin periodinane (125 mg, 0.29 mmol) was added in one portion to a 
solution of compound 40b (46 mg, 0.27 mmol) in CH2Cl2 (1.8 mL). 
After stirring for 30 min, the reaction was quenched with aq. sat. 
NaHCO3 and the mixture diluted with hexanes before it was filtered 
through a pad of Celite. The aqueous phase was extracted with hexanes, and the combined 
organic phases were washed with brine, dried over MgSO4 and evaporated. The residue was 
triturated with hexanes, insoluble residues were filtered off through a pad of Celite, and the 
filtrate was evaporated to give crude 41 which was immediately used in the next operation. 
COOEtI
A solution of crude 41 thus formed and CHI3 (173 mg, 0.440 mmol) in 1,4-dioxane (3.6 mL) was 
added dropwise to a suspension of CrCl2.1.8 THF (278 mg, 1.1 mmol) in THF (0.7 mL). After 
stirring for 1 h, H2O was introduced, the mixture was concentrated under vacuum, the aqueous 
phase was repeatedly extracted with tert-butyl methyl ether, the combined organic extracts were 
washed with brine, dried over MgSO4 and evaporated, and the residue purified by flash 
chromatography (hexanes/Et2O, 1:0→25:1) to give product 43 as a colorless oil (33 mg, 51%, 
containing < 15% 42). = +30 (c = 0.05, CH[ ]20Dα 2Cl2); 1H NMR (400 MHz, CD2Cl2): δ (major 
product 43) = 6.52-6.48 (m, 1H), 6.49 (dd, J = 14.5, 6.8 Hz, 1H), 6.10 (dd, J = 14.5, 1.3 Hz, 1H), 
4.16 (q, J = 7.1 Hz, 2H), 3.30-3.20 (m, 1H), 1.84 (d, J = 1.5 Hz, 3H), 1.28 (t, J = 7.1 Hz, 3H), 
1.14 (t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CD2Cl2): δ (major product) = 168.1, 148.3, 142.4, 
128.5, 75.5, 61.0, 40.1, 19.5, 14.4, 12.7; IR (film): υ~  = 2973, 1711, 1447, 1367, 1248, 1179, 
1117, 947, 748, 720, 682 cm-1; HRMS (ESI): m/z: calcd for C10H15O2I+Na: 317.00109 [M++Na], 
found: 317.00090. 
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Fragment Coupling Reactions and Formation of Macrocycle 51 
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ompound 46. Compound 36 (358 mg, 0.86 mmol), compound 43 (containing ~10% of 42, 221 
T
C
mg, 0.75 mmol), CuTC (179 mg, 0.94 mmol) and Pd(PPh3)4 
(38 mg, 0.033 mmol) were successively added to a solution of 
thoroughly dried Ph2PO2NBu4 (432 mg, 0.94 mmol) in 
degassed DMF (8.4 mL). The resulting brown mixture was 
stirred for 1 h before it was diluted with H2O/EtOAc, and 
he organic phase was washed with brine before it was dried 
over Na
filtered through a pad of Celite. 
2SO4, and evaporated. The residue was purified by flash chromatography 
(hexanes/EtOAc, 20:1) to give product 46 as a colorless oil (175 mg, 80%, containing about 10% 
of other isomers which cannot be separated at this stage). [ ]20Dα = −25.8 (c = 1.2, CHCl3); 1H 
NMR (400 MHz, CDCl3): δ = 6.60 (d, J = 9.7 Hz, 1H), 6.08  = 15.7 Hz, 1H), 5.77 (m, 1H), 
5.57 (dd, J = 15.7, 6.8 Hz, 1H), 5.28 (d, J = 9.0 Hz, 1H), 5.05 (m, 2H), 4.19 (q, J = 7.1 Hz, 2H), 
4.04 (m, 1H), 3.28 (m, 1H), 3.24 (s, 3H), 2.37 (m, 1H), 2.23 (m, 1H), 1.87 (s, 3H), 1.77 (s, 3H), 
1.29 (t, J = 7.1 Hz, 3H), 1.16 (d, J = 6.7 Hz, 3H); 
(d, J
13C NMR (100 MHz, CDCl3): δ = 168.4, 144.8, 
136.5, 134.6, 133.5, 131.5 (2x), 126.8, 117.0, 76.9, 60.6, 56.1, 40.1, 36.4, 20.4, 14.4, 13.1, 12.6; 
IR (film): υ~  = 2977, 2929, 2873, 1711, 1643, 1448, 1367, 1263, 1240, 1098, 966, 750 cm-1; 
HRMS (ESI): m/z: calcd for C18H28O3+Na: 315.193066 [M++Na]; found: 315.192829. 
Compound 47. A solution of LiOH (1.5 mL, 1 M in H2O) was added to a solution of compound 
e
46 (66 mg, 0.226 mmol, about 90% of the main isomer) in 
MeOH (1 mL) and THF (1 mL) and the resulting mixture was 
stirred for 24 h. For work up, the mixture was acidified to a 
pH ≈ 3 with aq. HCl (0.5 M) and extracted with EtOAc. The 
combined organic extracts were washed with brine, dried over 
sidue purified by flash chromatography (hexanes/EtOAc, 4:1) 
to give isomerically and analytically pure product 47 as a colorless oil (50 mg, 85%). 
Na2SO4 and evaporated, and the r [ ]20Dα = 
−42.7 (c = 1.2, CHCl3); 1H NMR (400 MHz, CD2Cl2): δ = 6.75 (dd, J = 9.8, 1.2 Hz, 1H), 6.11 (d, 
J = 15.7 Hz, 1H), 5.82-5.70 (m, 1H), 5.61 (dd, J = 15.7, 6.9 Hz, 1H), 5.27 (d, J = 9.0 Hz, 1H), 
5.08-4.99 (m, 2H), 4.10-4.00 (m, 1H), 3.38-3.23 (m, 1H), 3.31 (s, 3H), 2.40-2.30 (m, 1H), 2.27-
2.18 (m, 1H), 1.87 (d, J = 1.2 Hz, 3H), 1.78 (d, J = 1.2 Hz, 3H), 1.17 (d, J = 6.8 Hz, 3H); 13C 
NMR (100 MHz, CD2Cl2): δ = 174.3, 148.3, 137.2, 135.5, 134.4, 132.5, 131.8, 126.6, 117.2, 
77.5, 56.4, 40.7, 37.3, 20.7, 13.6, 12.7; IR (film): υ~  = 2964, 2927, 1683, 1640, 1418, 1274, 1094, 
963 cm-1; HRMS (ESI): m/z: calcd for C16H24O3-H: 263.165268 [M--H]; found: 263.165497. 
Compound 48. Pd(dppf)Cl2 (3 mg, 0.0039 mmol) and Ba(OH)2·8H2O (12 mg, 0.039 mmol) were 
added to a solution of compounds 19 (9 mg, 0.031 mmol) and 30 (11 mg, 0.026 mmol) in DMF 
(0.6 mL). The mixture was vigorously stirred at 40ºC for 3 h, before it was diluted with EtOAc 
and quenched with ice water. The aqueous phase was repeatedly extracted with EtOAc, the 
combined organic extracts were washed with brine, dried over MgSO4 and evaporated, and the 
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oil (8.0 mg, 66%). [ ]20Dα = +13 (c = 0.14, CH2Cl2); 1H NMR (400 MHz, CD2Cl2): δ = 6.69 (dd, J 
= 17.4, 10.9 Hz, 1H), 6.08 (m, 4H), 5.30 (m, 1H), 5.23 (m, 2H), 5.10 (d, J = 17.4 Hz, 1H), 4.99 
(d, J = 10.8 Hz, 1H), 4.60 (brs, 1H), 3.62 
(m, 3H), 3.43 (m, 1H), 3.12 (s, 3H), 2.14 
(m, 2H), 2.10 (m, 2H), 1.72 (s, 3H), 1.66 (s, 
3H), 1.64 (s, 3H), 1.45 (m, 2H), 1.35 (s, 
9H), 0.79 (d, J = 6.7 Hz, 3H); 13C NMR 
(100 MHz, CD2Cl2): δ = 135.8, 132.9, 
132.0, 131.6, 130.2, 129.8 (2x), 122.1, 119.5, 112.3, 80.9, 80.4, 55.1, 47.3, 40.4, 34.8, 27.3, 22.4, 
18.7, 16.1, 13.8, 10.7; IR (film): υ~  = 3415, 3348,3088, 2974, 2929, 2871, 2822, 1700, 1659, 
1595, 1512, 1453, 1390, 1366, 1250, 1170, 1099, 991, 935, 868, 802 cm-1; HRMS (ESI): m/z: 
calcd for C28H45NO4+Na: 482.324190 [M++ Na]; found: 482.324076. 





DMAP (3 mg, 0.022 mmol) were 
c
(hexanes/EtOAc, 4:1) to give compound 49 as a yellow
added to a solution of compounds 47 (13 
mg, 0.044 mmol) and 48 (13 mg, 0.029 
mmol) in toluene (1 mL) and the 
resulting mixture was stirred at ambient 
temperature for 4 days. The crude 
t purified by flash chromatography 
 oil (15 mg, 73 %). 
mixture was adsorbed on silica and the produ
1H NMR (300 MHz, 
CD2Cl2): δ = 6.77 (dd, J = 17.3, 11.2 Hz, 1H), 6.57 (dd, J = 9.7, 1.4 Hz, 1H), 6.25 (d, J = 10.4 
Hz, 1H), 6.17-6.02 (m, 4H), 5.76 (m, 1H), 5.59 (m, 2H), 5.43-5.28 (m, 2H), 5.26-5.13 (m, 2H), 
5.10-4.97 (m, 4H), 4.70 (bs, 1H), 4.04 (m, 1H), 3.69 (d, J = 5.8 Hz, 2H), 3.49 (q, J = 6.8 Hz, 1H), 
3.25-3.19 (m, 1H), 3.20 (s, 3H), 3.17 (s, 3H), 2.62 (m, 1H), 2.34 (m, 1H), 2.26-2.13 (m, 3H), 1.83 
(d, J = 1.5 Hz, 3H), 1.80 (d, J = 0.9 Hz, 3H), 1.76 (d, J = 1.1 Hz, 3H), 1.74 (s, 6H), 1.66-1.55 (m, 
2H), 1.43 (s, 9H), 1.13 (d, J = 6.7 Hz, 3H), 0.96 (d, J = 6.7 Hz, 3H); 13C NMR (75 MHz, 
CD2Cl2): δ = 167.4, 156.1, 145.1, 136.8, 136.7, 136.3, 135.2, 134.3, 134.1, 133.7, 133.1, 132.9, 
132.7, 131.9, 131.8, 131.0, 130.6, 127.1, 124.4, 120.3, 116.8, 113.4, 83.0, 81.6, 77.1 (2x), 56.1, 
56.0, 48.4, 40.4, 39.9, 36.6, 36.0, 28.5, 23.6, 20.5, 19.9, 17.0, 15.0, 13.2, 12.7, 12.6; IR (film): υ~  
= 3355, 3073, 2974, 2929, 2874, 2817, 1713, 1644, 1585, 1508, 1450, 1389, 1366, 1262, 1168, 
1099, 990, 968 cm-1; HRMS (ESI): m/z: calcd for C44H67NO6+Na: 728.486059 [M++Na]; found: 
728.485578. 
Compound 51. Complex 50 (0.6 mg, 0.00071 mmol) was added to a solution of compound 49 (5 
mg, 0.007 mmol) in CH2Cl2 (10 mL) and the resulting solution was stirred at ambient 
temperature for 24 h. At that point, a second batch of 50 (0.6 mg, 0.00071 mmol) was introduced 
and stirring continued for additional 24 h. The reaction was then quenched with ethyl vinyl ether, 
all volatile materials were evaporated, and the residue purified by flash chromatography 
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CH2Cl2); 1H NMR (600 MHz, CD2Cl2): δ = 6.57 (dq, J = 10.3, 1.5 Hz, 1H), 6.47 (d, J = 15.4 Hz, 
1H), 6.30 (dq, J = 11.2, 1.3 Hz, 1H), 6.13 (dq, J = 11.2, 1.4 Hz, 1H), 6.04 (dd, J = 14.8, 10.5 Hz, 
1H), 5.97 (dd, J = 15.2, 10.5 Hz, 1H), 5.89 
(d, J = 15.5 Hz, 1H), 5.52 (ddd, J = 15.5, 
10.1, 4.5 Hz, 1H), 5.48 (dd, J = 15.4, 8.9 
Hz, 1H), 5.38 (dd, J = 15.2, 8.0 Hz, 1H), 
5.37 (dd, J = 14.8, 9.2 Hz, 1H), 5.18 (dd, J 
= 9.2, 6.0 Hz, 1H), 5.10 (d, J = 10.1 Hz, 
1H), 5.08 (d, J = 9.8 Hz, 1H), 4.68 (brs, 
2H), 3.26 (ddd, J = 10.4, 8.0, 3.2 Hz, 1H), 
3.6 Hz, 1H), 2.54 (tq, J = 9.6, 6.9 Hz, 1H), 
2.53-2.51 (m, 1H), 2.30 (ddd, J = 13.7, 10.0, 10.0 Hz, 1H), 1.90 (dq, J = 13.6, 6.0 Hz, 1H), 1.78 
(s, 3H), 1.77 (s, 3H), 1.77 (d, J = 1.3 Hz, 3H), 1.75 (s, 3H), 1.74 (d, J = 1.2 Hz, 3H), 1.58 (ddt, J 
= 13.9, 9.7, 4.8 Hz, 1H), 1.43 (s, 9H), 1.29 (dddd, J = 14.0, 11.2, 5.3, 3.3 Hz, 1H), 1.04 (d, J = 
6.7 Hz, 3H), 0.92 (d, J = 6.8 Hz, 1H);
1H), 4.11 (ddd, J = 10.0, 9.5, 2.8 Hz, 1H), 3.70 (m, 
3.21 (s, 3H), 3.14 (m, 1H), 2.94 (s, 3H), 2.63 (d, J = 1
 13C NMR (150 MHz, CD2Cl2): δ = 167.6, 156.2, 145.6, 
137.2, 137.1, 136.3, 133.8, 133.7, 133.3, 133.1, 132.4, 132.3, 132.1, 131.2, 129.8, 128.8, 126.0, 
125.7, 125.4, 120.3, 83.3, 79.8, 77.9, 77.0, 56.5, 55.9, 48.4, 41.0, 41.0, 38.3, 35.3, 28.5, 23.2, 
21.5, 20.8, 16.8, 15.1, 13.2, 12.1, 12.1; HRMS (ESI): m/z: calcd for C42H63NO6+Na: 700.4552 
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‘First Generation’ Total Synthesis of Iejimalide B 
 
Compound 52. TMSOTf (50 μL, 0.279 mmol) was added dropwise to a solution of 2,6-lutidine 
(38 μL, 0.325 mmol) in CH2Cl2 (0.5 mL) at 0°C. After 
stirring for 5 min, the resulting solution was transferred via 
syringe to a solution of compound 29 (47 mg, 0.093 mmol) 
in CH2Cl2 (1 mL) at 0°C. The resulting mixture was stirred 
for 3 h before the reaction was quenched with aq. sat. 
NaHCO3, the aqueous phase was extracted with CH2Cl2, the 
combined organic phases were washed with aq. CsF (0.5 M), and the fluoride solution was 
extracted with CH2Cl2. The combined organic extracts were washed with brine before being dried 
over Na2SO4 and evaporated.  
Compound 57 (30 mg, 0.12 mmol), N-methylmorpholine (30 μL, 0.28 mmol) and HOBt (15 mg, 
0.11 mmol) were successively added to a solution of the crude amine thus formed in CH2Cl2 (2 
mL). The resulting solution was cooled to 0oC before EDC (25 mg, 0.13 mmol) was introduced 
and stirring continued overnight at ambient temperature. The mixture was evaporated and the 
residue partitioned between H2O and EtOAc. The combined organic layers were washed with aq. 
HCl (0.1 M) and brine, before they were dried over Na2SO4 and evaporated. Flash 
chromatography of the residue (hexanes/EtOAc, 55:45) afforded product 52 as a colorless oil (50 
mg, 85%). = +11.8 (c = 1.35, CHCl[ ]20Dα 3); 1H NMR (400 MHz, CD2Cl2): δ = 8.23 (s, 1H), 6.60-
6.50 (bs, 2H), 6.40 (dd, J = 14.4, 8.8 Hz, 1H), 6.22-6.08 (m, 3H), 4.93 (d, J = 8.3 Hz, 1H), 4.43-
4.38 (m, 1H), 4.10-4.00 (m, 1H), 3.97-3.80 (m, 2H), 3.62 (dd, J = 9.8, 7.7 Hz, 1H), 2.62-2.53 (m, 
1H), 1.75 (s, 3H), 1.71 (s, 3H), 1.18 (s, 9H), 0.93 (d, J = 6.9 Hz, 3H), 0.88 (s, 9H), 0.09 (d, J = 
9.8 Hz, 6H); 13C NMR (100 MHz, CD2Cl2): δ = 177.7, 170.2, 161.6, 148.5, 136.0, 134.5, 124.8, 
122.0, 81.8, 76.6, 63.5, 47.8, 44.0, 39.6, 27.7, 26.3, 18.8, 16.9, 15.6, 13.0, −5.1; IR (film): υ~  = 
3303, 2957, 2929, 2857, 1727, 1650, 1534, 1383, 1245, 1150, 836 cm-1; HRMS (ESI): m/z: calcd 
for C27H47N2O5NaSiI: 657.219121 [M++Na]; found: 657.219663. 
Compound 53. A solution of LiBEt3H (236 μL, 1.0 M in THF) was added dropwise to a solution 
of compound 52 (50 mg, 0.0788 mmol) in THF (2 mL) at 
0°C and the resulting mixture was stirred for 1 h before 
additional LiBEt3H (39 μL, 1.0 M in THF) was introduced. 
After 30 min, a third portion of LiBEt3H (39 μL, 1.0 M in 
THF) was added and stirring continued for another 30 min. 
At this point the solution was neutralized with aq. sat. 
NH4Cl, the aqueous phase was extracted with tert-butyl 
methyl ether, the combined organic layers were washed with brine, dried over Na2SO4 and 
evaporated, and the residue was purified by flash chromatography (hexanes/EtOAc, 1:1) to give 
product 53 as a colorless oil (30 mg, 70%). [ ]20Dα = +29.3 (c = 1.0, CH2Cl2); 1H NMR (400 MHz, 

















   
S-32 
9.8, 4.0 Hz, 1H), 3.98-3.81 (m, 2H), 3.78 (d, J = 7.9 Hz, 1H), 3.62 (dt, J = 8.8, 1.9 Hz, 1H), 2.44-
2.35 (m, 1H), 1.74 (s, 3H), 1.71 (s, 3H), 0.90-0.85 (m, 12H), 0.10 (s, 3H). 0.08 (s, 3H); 13C NMR 
(100 MHz, CD2Cl2): δ = 170.2, 161.6, 149.6, 138.5, 135.3, 123.5, 122.3, 81.7, 76.4, 63.5, 53.4, 
47.8, 45.2, 26.3, 18.8, 16.8, 15.5, 12.4, −5.0; IR (film): υ~  = 3302, 2928, 2857, 1650, 1530, 1385, 
1255, 1107, 953, 834, 710 cm-1; HRMS (ESI): m/z: calcd for C22H39N2O4ISi+Na: 573.161605 
[M++Na]; found: 573.161674. 
Compound 54. Pd(dppf)Cl2 (4.0 mg, 0.0054 mmol) and Ba(OH)2·8H2O (17 mg, 0.054 mmol) 
were added to a solution of 
compounds 19 (12 mg, 0.040 mmol) 
and 53 (20 mg, 0.036 mmol) in DMF 
(0.8 mL). The mixture was 
vigorously stirred at 20ºC for 3 h 
before it was diluted with tert-butyl 
 phase was extracted with tert-butyl 
methyl ether, and the combined organic extracts were repeatedly washed with brine before they 
were dried over MgSO
methyl ether and quenched with ice water. The aqueous
δ =
1
4 and evaporated. Purification of the residue by flash chromatography 
(hexanes/EtOAc, 5:1→1:1) furnished product 54 as a colorless oil (15 mg, 70%). [ ]20Dα = +6.3 (c 
= 0.5, CH2Cl2); 1H NMR (400 MHz, CD2Cl2):  8.26 (s, 1H), 6.76 (ddd, J = 17.3, 10.8, 0.6 Hz, 
1H), 6.61-6.59 (brm, 2H), 6.20-6.13 (m, 4H), 5.63 (dd, J = 12.1, 3.9 Hz, 1H), 5.46 (dd, J = 14.4, 
8.1 Hz, 1H), 5.36 (t, J = 7.2 Hz, 1H), 5.18 (d, J = 17.3 Hz, 1H), 5.07 (d, J = 10.8 Hz, 1H), 4.49-
4.44 (m, 1H), 4.09 (dd, J = 9.6, 4.0 Hz, 1H), 3.96-3.86 (m, 2H), 3.75 (d, J = 8.5 Hz, 1H), 3.58 
(dd, J = 9.6, 8.4 Hz, 1H), 3.56-3.50 (m, 1H), 3.24 (s, 3H), 2.38 (m, 1H), 2.21-2.18 (m, 2H), 1.81 
(s, 3H), 1.75 (s, 3H), 1.74 (s, 9H), 1.68-1.50 (m, 2H), 0.90 (d, J = 8.1 Hz, 3H), 0.88 (s, 9H), 0.115 
(s, 6H); 13C NMR (100 MHz, CD2Cl2): δ = 169.2, 160.6, 137.5, 135.9, 133.5, 133.4, 132.6, 
32.4, 132.0, 131.0, 130.1, 122.8, 121.8, 113.0, 81.5, 80.9, 75.9, 62.2, 55.9, 52.5, 47.0, 40.9, 
35.2, 25.5, 22.9, 19.5, 17.7, 16.7, 14.6, 11.4, −5.8, −5.9; IR (film): υ~  = 3286, 2929, 2859, 1652, 
1548, 1462, 1386, 1257, 1106, 990, 837, 778 cm-1; HRMS (ESI): m/z: calcd for 
C33H56N2O5Si+Na: 611.385351 [M++ Na]; found: 611.385069. 
Compound 55. DCC (5.3 mg, 0.0255 mmol) and 4-pyrrolidinyl-pyridine (1.2 mg, 0.0076 mmol) 
were added in portions to a 
solution of acid 47 (7.5 mg, 
0.0255 mmol) in CH2Cl2 (0.1 
mL) at 0ºC. After stirring for 10 
min, the mixture was cooled to 
0ºC and a solution of compound 
54 (15 mg, 0.0255 mmol) in THF 
(0.1 mL) was added dropwise. The mixture was allowed to reach ambient temperature and was 
stirred for 17 h before being filtered through a pad of Celite. Evaporation of the filtrate followed 
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product 55 as a pale yellow oil (18 mg, 85%). [ ]20Dα = +10 (c = 1.1, CH2Cl2); 1H NMR (400 MHz, 
CD2Cl2): δ = 8.22 (s, 1H), 6.76 (ddd, J = 16.2, 11.1, 0.6 Hz, 1H), 6.56 (dd, J = 9.6, 1.2 Hz, 1H), 
6.51-6.48 (brm, 2H), 6.23 (d, J = 10.2 Hz, 1H), 6.15-6.06 (m, 4H), 5.77 (ddt, J = 17.4, 10.2, 7.2 
Hz, 1H), 5.61-5.57 (m, 2H), 5.41-5.33 (m, 2H), 5.24 (d, J = 9.0 Hz, 1H), 5.19 (d, J = 17.4 Hz, 
1H), 5.07-5.05 (m, 4H), 4.42 (td, J = 6.6, 4.2 Hz, 1H), 4.07-4.00 (m, 2H), 3.62 (dd, J = 9.6, 7.8 
Hz, 1H), 3.50 (dd, J = 12.6, 7.8 Hz, 1H), 3.29-3.20 (m, 1H), 3.21 (s, 3H), 3.18 (s, 3H), 2.55 (m, 
1H), 2.25-2.18 (m, 2H), 1.85 (d, J = 1.2 Hz, 3H), 1.82 (d, J = 1.2 Hz, 3H), 1.79 (d, J = 1.2 Hz, 
3H), 1.76 (bs, 6H), 1.65-1.60 (m, 1H), 1.52-1.46 (m, 1H), 1.15 (d, J = 6.6 Hz, 3H), 0.98 (d, J = 
6.6 Hz, 3H), 0.90 (s, 9H), 0.13 (s, 6H); 13C NMR (100 MHz, CD2Cl2): δ = 169.8 167.4, 161.1, 
145.1, 136.8, 136.2, 135.3, 135.2, 134.9, 134.1, 133.7, 133.1, 132.9, 132.7, 131.9, 131.9, 131.0, 
130.7, 127.1, 124.3, 121.8, 116.8, 113.4, 83.0, 81.6, 77.1, 63.1, 56.1, 56.0, 53.5, 47.4, 40.4, 39.9, 
36.7, 36.0, 25.9, 23.6, 20.5, 19.8, 18.4, 17.0, 15.2, 13.2, 12.8, 12.6, −5.4, −5.5; IR (film): υ~  = 
3294, 2926, 2855, 1733, 1653 (br), 1547, 1462, 1378, 1259 cm-1; HRMS (ESI): m/z: calcd for 
C49H78N2O7Si+Na: 857.547735 [M++Na]; found: 857.547048.  
Compound 56. Complex 50 (2.7 mg, 0.00324 mmol) was added to a solution of compound 55 
(18 mg, 0.0216 mmol) in CH2Cl2 
(22 mL) and the resulting mixture 
was stirred at ambient temperature 
for 48 h. The reaction was quenched 
with ethyl vinyl ether (20 µL). After 
stirring for 10 min, all volatile 
materials were evaporated while 
keeping the temperature of the bath at 20ºC. The residue was adsorbed on Celite and purified by 
flash chromatography (hexanes/EtOAc, 3:1→1.5:1) to give product 56 as a yellow oil (10 mg, 
69%). = +4 (c = 0.54, CH[ ]20Dα 2Cl2); 1H NMR (600 MHz, CD2Cl2): δ = 8.22 (s, 1H), 6.57 (dd, J = 
10.3, 1.3 Hz, 1H), 6.56-6.48 (m, 2H), 6.46 (d, J = 15.5 Hz, 1H), 6.28 (d, J = 11.6 Hz, 1H), 6.15 
(d, J = 11.6 Hz, 1H), 6.04 (dd, J = 14.6, 10.2 Hz, 1H), 5.97 (dd, J = 15.2, 10.2 Hz, 1H), 5.89 (d, J 
= 15.4 Hz, 1H), 5.52 (ddd, J = 15.5, 10.2, 4.8 Hz, 1H), 5.48 (dd, J = 15.4, 8.9 Hz, 1H), 5.40-5.35 
(m, 2H), 5.19-5.17 (m, 1H), 5.09 (d, J = 10.1 Hz, 1H), 5.08 (d, J = 8.8 Hz, 1H), 4.44-4.41 (m, 
1H), 4.12 (ddd, J = 9.8, 9.6, 2.8 Hz, 1H), 4.06 (dd, J = 9.7, 3.9 Hz, 1H), 3.95-3.83 (m, 2H), 3.62 
(dd, J = 9.7, 7.7 Hz, 1H), 3.29-3.24 (m, 1H), 3.22 (s, 3H), 3.19-3.14 (m, 1H), 2.96 (s, 3H), 2.64 
(brd, J = 12.8 Hz, 1H), 2.58-2.52 (m, 2H), 2.31 (dt, J = 12.8, 9.8 Hz, 1H), 1.91-1.86 (m, 1H), 
1.79 (s, 3H), 1.78 (brs, 6H), 1.77 (s, 3H), 1.76 (s 3H), 1.63-1.59 (m, 1H), 1.30-1.28 (m, 1H), 1.06 
(d, J = 6.7 Hz, 3H), 0.93 (d, J = 6.8 Hz, 3H) 0.90 (s, 9H), 0.13 (s, 6H); 13C NMR (150 MHz, 
CD2Cl2): δ = 169.8, 167.5, 161.1, 145.6, 137.1, 136.2, 135.8, 134.3, 133.8, 133.8, 133.3, 132.4, 
132.3, 132.0, 131.2, 129.8, 128.8, 125.9, 125.5, 125.4, 121.8, 83.2, 79.8, 77.0, 63.0, 56.5, 55.9, 
53.8, 47.4, 41.0, 40.9, 38.3, 35.3, 25.9, 23.2, 21.5, 20.8, 18.4, 16.8, 15.2, 13.2, 12.1, 12.1,  
−5.4, −5.5; IR (film): υ~  = 3300, 2926, 2856, 1651 (br), 1533, 1462, 1385, 1257, 1216, 1105, 
989, 964, 837, 778, 744 cm-1; HRMS (ESI): m/z: calcd for C47H74N2O7Si+Na: 829.515918 
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Iejimalide B (2). A solution of TBAF (6.5 µL, 1 M in THF) was added dropwise to a solution of 
compound 56 (5 mg, 0.0062 mmol) 
in THF (62 µL) at 0ºC. After stirring 
at that temperature for 15 min, 
hexane (100 µL) was added and the 
mixture was adsorbed on silica. 
Purification by flash chromatography 
(hexanes/EtOAc, 2:1→0:1) furnished 
product 2 as a colorless oil (4 mg, 80%). The spectroscopic data are in full agreement to those 
published for natural 2.14 = −16 (c = 0.2, CH[ ]20Dα 2Cl2) (Lit14a: −17.6, CHCl3); 1H NMR (600 
MHz, CD2Cl2): δ = 8.26 (s, 1H), 6.70 (d, J = 6.5 Hz, 1H), 6.63 (t, J = 5.8 Hz, 1H), 6.58 (dq, J = 
10.4, 1.4 Hz, 1H), 6.45 (d, J = 16.1 Hz, 1H), 6.28 (dd, J = 11.2, 1.5 Hz, 1H), 6.14 (dq, J = 11.2, 
1.4 Hz, 1H), 6.05 (dd, J = 14.5, 10.5 Hz, 1H), 5.99 (dd, J = 15.2, 10.5 Hz, 1H), 5.89 (d, J = 15.5 
Hz, 1H), 5.52 (ddd, J = 15.1, 10.1, 4.8 Hz, 1H), 5.49 (dd, J = 15.5, 8.9 Hz, 1H), 5.39 (dd, J = 
14.0, 9.1 Hz, 1H), 5.38 (dd, J = 14.5, 8.4 Hz, 1H), 5.20-5.17 (m, 1H), 5.09 (d, J = 9.8 Hz, 1H), 
5.07 (d, J = 9.7 Hz, 1H), 4.48-4.46 (m, 1H), 4.15-4.09 (m, 2H), 3.92-3.85 (m, 2H), 3.64 (ddd, J = 
11.3, 8.6, 4.9 Hz, 1H), 3.30-3.25 (m, 1H), 3.21 (s, 3H), 3.19-3.14 (m, 1H), 3.01 (dd, J = 8.6, 3.9 
Hz, 1H), 2.96 (s, 3H), 2.65-2.61 (m, 1H), 2.58-2.47 (m, 2H), 2.29 (dt, J = 13.8, 10.2 Hz, 1H), 
1.91-1.86 (m, 1H), 1.78 (d, J = 0.9 Hz, 3H), 1.77 (s, 6H), 1.75 (d, J = 0.7 Hz, 3H), 1.73 (d, J = 
1.2 Hz, 3H), 1.61-1.58 (m, 1H), 1.33-1.30 (m, 1H), 1.05 (d, J = 6.7 Hz, 3H), 0.93 (d, J = 6.8 Hz, 
3H); 13C NMR (150 MHz, CD2Cl2): δ = 170. 7, 167.5, 161.8, 145.6, 137.2, 136.1, 135.5, 134.4, 
133.7, 133.7, 133.3, 132.4, 132.3, 132.1, 131.2, 129.8, 128.8, 126.0, 125.3, 125.1, 121.2, 83.1, 
80.0, 77.1, 62.8, 56.5, 55.9, 52.9, 47.1, 41.0, 40.8, 38.2, 35.3, 23.3, 21.5, 20.8, 16.8, 15.2, 13.2, 
12.3, 12.1; IR (film): υ~  = 3329, 2925, 2856, 1654 (br), 1541, 1453, 1383, 1260, 1096, 965, 800, 












                                                   
14  (a) Kobayashi, J.; Cheng, J.; Ohta, T.; Nakamura, H.; Nozoe, S.; Hirata, Y.; Ohizumi, Y.; Sasaki, T. J. 
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Bioorg. Med. Chem. 2006, 14, 1063. (d) Tsuda, M.; Nozawa, K.; Shimbo, K.; Ishiyama, H.; Fukushi, 
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Iejimalide D (4). SO3.Py (17 mg, 0.108 mmol) and DMF (50 µL) were successively added to a 
solution of 2 (1.5 mg, 0.0022 mmol) in pyridine (100 µL) and the resulting mixture was stirred 
for 1h. All volatiles were evaporated under a flow of argon, and the residue was dissolved in 
EtOAc. Filtration through Celite, 
evaporation of the solvent, and 
purification of the residue by 
HPLC (CH3CN + 0.1% trifluoro-
acetic acid) gave, after 
lyophilization of the product- 
containing fractions, compound 4 as a white solid (0.7 mg, 42%). 1H NMR (600 MHz, CD2Cl2): 
δ = 8.16 (s, 1H), 6.60 (dd, J = 10.4, 1.4 Hz, 1H), 6.46 (d, J = 16.1 Hz, 1H), 6.30 (d, J = 11.1 Hz, 
1H), 6.19 (d, J = 11.1 Hz, 1H), 6.06 (dd, J = 15.0, 10.5 Hz, 1H), 5.96-5.92 (m, 2H), 5.60-5.50 (m, 
1H), 5.39-5.33 (m, 2H), 5.20-5.17 (m, 1H), 5.10 (d, J = 10.1 Hz, 1H), 5.08 (d, J = 9.7 Hz, 1H), 
4.68 (t, J = 5.0 Hz, 1H), 4.29 (dd, J = 10.7, 5.6 Hz, 1H), 4.23-4.20 (m, 2H), 3.83-3.79 (m, 2H), 
3.26 (m, 1H), 3.23 (s, 3H), 3.22 (m, 1H), 2.96 (s, 3H), 2.66-2.63 (m, 1H), 2.59-2.51 (m, 2H), 
2.30-2.24 (m, 1H), 1.88-1.86 (m, 1H), 1.81 (s, 3H), 1.78 (s, 6H), 1.76 (s, 3H), 1.75 (d, J = 0.6 Hz, 
3H), 1.61-1.55 (m, 1H), 1.05 (d, J = 6.6 Hz, 3H), 0.91 (d, J = 6.8 Hz, 3H); HRMS (ESI): m/z: 
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Total Synthesis of Iejimalide B – ‘Teoc-Strategy’ 
 
Compound 58. TFA (10 mL, 130 mmol)) was added dropwise to a solution of compound 23 
(799 mg, 2.97 mmol) in CH2Cl2 (35 mL) at 0°C. The 
mixture was stirred at ambient temperature for 1 h 
before it was evaporated and the crude amine thus 






Et3N (2.8 mL, 20 mmol) and 4-nitrophenyl-2-trimethylsilylethyl-carbonate (1.7 g, 6 mmol) were 
added to a solution of the crude amine in CH2Cl2 (35 mL). The resulting yellow solution was 
stirred for 24 h before it was extracted with aq. sat. Na2CO3 to remove the released nitrophenol. 
The mixture was washed with brine, the organic layer was dried over Na2SO4 and evaporated, 
and the crude product purified by flash chromatography (hexanes/EtOAc, 4:1) to give product 58 
as a pale yellow oil (887 mg, 96%). 1H NMR (400 MHz, CD2Cl2): δ = 7.43 (d, J = 11.8 Hz, 1H), 
6.24 (d, J = 11.8 Hz, 1H), 4.98 (bs, 1H), 4.16 (t, J = 8.3 Hz, 2H), 3.82 (d, J = 6.0 Hz, 2H), 3.72 
(s, 3H), 1.92 (s, 3H), 1.86 (s, 3H), 0.98 (t, J = 8.3 Hz, 2H), 0.05 (s, 9H); 13C NMR (100 MHz, 
CD2Cl2): δ = 169.2, 157.1, 144.0, 133.6, 126.8, 120.3, 63.5, 52.0, 48.5, 18.0, 15.6, 13.0, −1.5; IR 
(film): υ~  = 3348, 2952, 1695, 1523, 1434, 1244, 1110, 1059, 941, 834, 751 cm-1; HRMS (ESI): 
m/z: calcd for C15H27NO4Si+Na: 336.160159 [M++Na]; found: 336.160418; elemental analysis 
calcd (%) for C15H27NO4Si: C 57.47, H 8.68; found: C 57.40, H 8.72.  
Compound 59. DIBAl-H (6.5 mL, 1 M in hexane) was added dropwise to a solution of 
compound 58 (770 mg, 2.46 mmol) in CH2Cl2 (17 mL) at −78°C. 
After stirring for 1 h at that temperature, the reaction was quenched 
with EtOAc (2 mL) and the mixture was allowed to reach ambient 
temperature at which point sat. aq. Rochelle salt solution (10 mL) was introduced. After stirring 
at 40°C for 1 h, the mixture was diluted with EtOAc and extracted with brine, the combined 
organic layers were dried over Na2SO4 and evaporated, and the residue was purified by flash 
chromatography (hexanes/EtOAc, 2:1) to give product 59 as a white solid (671 mg, 95%). 1H 
NMR (400 MHz, CD2Cl2): δ = 6.25 (d, J = 11.2 Hz, 1H), 6.15 (d, J = 11.2 Hz, 1H), 4.80 (bs, 
1H), 4.14 (t, J = 8.4 Hz, 2H), 4.04 (s, 2H), 3.76 (d, J = 6.1 Hz, 2H), 1.76 (s, 3H), 1.75 (s, 3H), 
1.63 (s, 1H), 0.98 (t, J = 8.4 Hz, 2H), 0.04 (s, 9H); 13C NMR (100 MHz, CD2Cl2): δ = 157.0, 
137.7, 135.2, 121.1, 120.3, 68.8, 63.3, 48.8, 18.0, 14.9, 14.2, −1.5; IR (film): υ~  = 3331, 2954, 
2914, 1689, 1531, 1346, 1246, 1130, 1063, 1001, 832, 690, 664 cm-1; HRMS (ESI): m/z: calcd 
for C14H27NO3Si+Na: 308.165245 [M++Na]; found: 308.165153; elemental analysis calcd (%) for 
C14H27NO3Si: C 58.91, H 9.53; found: C 58.84, H 9.57.  
NHTeoc
HO
Compound 61. MnO2 (8.5 g, 97 mmol) was added to a solution of compound 59 (827 mg, 2.9 
mmol) in CH2Cl2 (30 mL) and the resulting mixture was stirred for 1 h. After filtration through a 
pad of Celite and evaporation of the filtrate, aldehyde 60 was obtained in quantitative yield and 
used directly in the next step. Characteristic data: 1H NMR (400 MHz, CD2Cl2): δ = 9.45 (s, 1 H), 
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7.13 (d, J = 11.6 Hz, 1H), 6.44 (d, J = 11.6 Hz, 1H), 4.98 (bs, 1H), 4.16 (t, J = 8.6 Hz, 2H), 3.87 
(d, J = 5.9 Hz, 2H), 1.97 (s, 3H), 1.82 (s, 3H), 0.99 (t, J = 8.6 Hz, 2H), 0.1 (s, 9H); 13C NMR 
(100 MHz, CD2Cl2): δ = 196.7, 158.4, 148.4, 145.4, 139.1, 121.4, 65.0, 50.0, 19.5, 17.3, 10.9, 
0.0; HRMS (ESI): m/z: calcd for C14H25NO3Si+H: 284.168201 [M++H]; found: 284.168231. 
Pd(OAc)2 (33 mg, 0.147 mmol) and PPh3 (40 mg, 0.152 
mmol) were added to a solution of compound 25 (1.32 g, 
4.3 mmol) in THF (30 mL) at –78°C. After stirring for 5 
min, a solution of the crude aldehyde 60 in THF (10 mL) 
was introduced followed by the dropwise addition of a 
solution of ZnEt2 (8.7 mL, 1.0 M in hexanes). The resulting mixture was stirred at that 
temperature for 30 min before it was warmed to –20°C over a period of 1 h and stirring was 
continued overnight. The reaction was quenched with aq. sat. NH4Cl, the aqueous phase was 
extracted with EtOAc, the combined organic layers were washed with brine, dried over Na2SO4 
and evaporated, and the crude material (d.r. = 7.5:1, NMR) was purified by flash chromatography 
(hexanes/EtOAc, 10:1→4:1) to give product 61 (dr > 15:1) as a colorless oil (1.02 g, 71%, ee = 
96.8%). = +47.5 (c = 0.9, CH[ ]20Dα 2Cl2); 1H NMR (400 MHz, CD2Cl2): δ = 6.26 (d, J = 11.2 Hz, 
1H), 6.16 (d, J = 11.2 Hz, 1H), 4.78 (bs, 1H), 4.15 (t, J = 8.4 Hz, 2H), 3.85 (dd, J = 7.0, 4.3 Hz, 
1H), 3.76 (d, J = 6.1 Hz, 2H), 2.75 (m, 1H), 2.29 (d, J = 4.3 Hz, 1H), 1.75 (s, 3H), 1.72 (s, 3H), 
1.13 (d, J = 6.9 Hz, 3H), 1.05 (m, 21H), 0.98 (t, J = 8.4 Hz, 2H), 0.04 (s, 9H); 13C NMR (100 
MHz, CD2Cl2): δ = 157.0, 136.9, 135.8, 123.1, 121.0, 110.3, 83.7, 81.0, 63.3, 48.8, 33.2, 18.8, 
18.2, 18.1, 15.0, 12.2, 11.5, −1.4; IR (film): υ~  = 3344, 2943, 2865, 2160, 1701, 1515, 1462, 
1382, 1249, 1124, 1060, 1016, 858, 835, 675 cm-1; HRMS (ESI): m/z: calcd for 
C27H51NO3Si2+Na: 516.329970 [M++Na]; found: 516.330321; elemental analysis calcd (%) for 




Compound 61b. A solution of TBAF (1.2 mL, 1 M in THF) was added in 4 portions over 2 h to a 
solution of compound 61 (501 mg, 1.01 mmol) in THF (20 mL) at 
0°C and the resulting mixture was stirred at that temperature for 30 
min. The reaction was then quenched with H2O, the aqueous phase 
extracted with EtOAc, the combined organic layers were washed 
with brine, dried over Na2SO4 and evaporated, and the residue was 
purified by flash chromatography (hexanes/EtOAc, 4:1) to give product 61b as a colorless oil 
(304 mg, 89%). [ ] = +49.3 (c = 1.55, CH20Dα 2Cl2); 1H NMR (400 MHz, CD2Cl2): δ = 6.25 (d, J = 
11.3 Hz, 1H), 6.15 (d, J = 11.3 Hz, 1H), 4.78 (bs, 1H), 4.15 (t, J = 8.7 Hz, 2H), 3.89 (d, J = 7.1 
Hz, 1H), 3.76 (d, J = 5.8 Hz, 2H), 2.69 (m, 1H), 2.18 (d, J = 2.3 Hz, 1H), 1.76 (s, 3H), 1.72 (s, 
3H), 1.10 (d, J = 7.2 Hz, 3H), 0.98 (t, J = 8.7 Hz, 2H), 0.04 (s, 9H); 13C NMR (100 MHz, 
CD2Cl2): δ = 158.4, 138.2, 137.6, 124.9, 122.2, 87.7, 82.5, 72.3, 64.7, 50.2, 33.1, 19.5, 19.3, 16.5, 
13.5, 0.0; IR (film): υ~  = 3310, 2970, 2953, 1737, 1721, 1520, 1372, 1248, 1230, 1217, 1058, 
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360.196099; elemental analysis calcd (%) for C18H31NO3Si: C 64.05, H 9.26; found: C 64.11, H 
9.30. 
Compound 61c. DMAP (10 mg, 0.08 mmol) and pivaloyl chloride (0.9 mL, 7.3 mmol) were 
successively added to a solution of compound 61b (546 mg, 1.61 
mmol) in pyridine (5 mL) at 0°C. The mixture was stirred at 
ambient temperature for 20 h before it was diluted with EtOAc 
and extracted with brine. The combined organic layers were dried 
over Na2SO4 and evaporated, and the residue purified by flash 
chromatography (hexanes/EtOAc, 10:1) to give product 61c as a colorless oil (643 mg, 94%). 
= +21.4 (c = 0.82, CH[ ]20Dα 2Cl2); 1H NMR (400 MHz, CD2Cl2): δ = 6.29 (d, J = 11.3 Hz, 1H), 
6.13 (d, J = 11.3 Hz, 1H), 5.06 (d, J = 7.7 Hz, 1H), 4.78 (bs, 1H), 4.14 (t, J = 8.3 Hz, 2H), 3.76 
(d, J = 5.9 Hz, 2H), 2.82 (m, 1H), 2.08 (d, J = 2.3 Hz, 1H), 1.76 (s, 3H), 1.74 (s, 3H), 1.21 (s, 
9H), 1.11 (d, J = 7.0 Hz, 3H), 0.98 (t, J = 8.3 Hz, 2H), 0.04 (s, 9H); 13C NMR (100 MHz, 
CD2Cl2): δ = 176.7, 156.4, 136.3, 133.8, 123.9, 119.8, 85.1, 80.4, 69.2, 62.7, 48.1, 38.6, 29.1, 
26.7, 17.4, 17.1, 14.5, 12.1, −2.0; IR (film): υ~  = 3314, 2970, 2955, 1725, 1520, 1366, 1248, 
1231, 1217, 1149, 1061, 966, 942, 858, 835, 693 cm-1; HRMS (ESI): m/z: calcd for 
C23H39NO4Si+Na: 444.254058 [M++Na]; found: 444.254501; elemental analysis calcd (%) for 




Compound 61d. A solution of compound 61c (260 mg, 0.616 mmol) in THF (7 mL) was added 
to a solution of Schwartz reagent (275 mg, 1.06 mmol) in THF (7 
mL). The mixture was stirred in the dark for 45 min before it was 
cooled to 0°C and a solution of iodine (270 mg, 1.06 mmol) in 
THF (5 mL) was introduced. After stirring for 5 min, the reaction 
was quenched with aq. sat. Na2S2O3, the mixture was stirred for 
10 min, diluted with EtOAc and extracted with brine. The 
combined organic layers were dried over Na2SO4 and evaporated, and the residue was purified by 
flash chromatography (hexanes/EtOAc, 10:1) to give product 61d as a colorless syrup (273 mg, 
81%). = +15.6 (c = 0.9, CH[ ]20Dα 2Cl2); 1H NMR (300 MHz, CD2Cl2): δ = 6.40 (dd, J = 14.4, 8.3 
Hz, 1H), 6.22 (d, J = 11.1 Hz, 1H), 6.10 (m, 2H), 4.93 (d, J = 8.2 Hz, 1H), 4.83 (bs, 1H), 4.14 (t, 
J = 8.6 Hz, 2H), 3.75 (d, J = 6.1 Hz, 2H), 2.57 (m, 1H), 1.75 (s, 3H), 1.71 (s, 3H), 1.18 (s, 9H), 
0.98 (t, J = 8.6 Hz, 2H), 0.93 (d, J = 6.9 Hz, 3H), 0.04 (s, 9H); 13C NMR (75 MHz, CD2Cl2): δ = 
177.3, 157.0, 148.2, 136.7, 133.7, 124.5, 120.5, 81.5, 76.1, 63.3, 48.7, 43.7, 39.2, 27.4, 18.0, 
16.5, 15.1, 12.6, −1.4; IR (film): υ~  = 3352, 2970, 2954, 1725, 1517, 1455, 1365, 1247, 1229, 
1217, 1149, 1061, 946, 858, 835, 766, 694 cm-1; HRMS (ESI): m/z: calcd for C23H40NO4SiI+Na: 
572.166357 [M++Na]; found: 572.166845; elemental analysis calcd (%) for C23H40NO4SiI: C 





Compound 62. A solution of LiBEt3H (1.2 mL, 1 M in THF) was added dropwise to a solution of 
compound 61d (195 mg, 0.355 mmol) in THF (20 mL) at 0°C. After stirring for 2 h at that 
temperature, the reaction was quenched with aq. sat. NH4Cl, diluted with EtOAc and extracted 
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with brine. The combined organic layers were dried over Na2SO4 and evaporated, and the crude 
product was purified by flash chromatography (hexanes/EtOAc, 4:1) to give compound 62 as a 
colorless oil (135 mg, 82%). [ ] = +28.1 (c = 1.05, CH20Dα 2Cl2); 1H NMR (300 MHz, CD2Cl2): δ = 
6.55 (dd, J = 14.5, 8.3 Hz, 1H), 6.15 (m, 3H), 4.76 (bs, 1H), 4.15 
(t, J = 8.4 Hz, 2H), 3.78 (m, 3H), 2.40 (m, 1H), 1.94 (bs, 1H), 1.76 
(s, 3H), 1.71 (s, 3H), 0.98 (t, J = 8.4 Hz, 2H), 0.91 (d, J = 6.8 Hz, 
3H), 0.05 (s, 9H); 13C NMR (75 MHz, CD2Cl2): δ = 157.0, 149.2, 
137.7, 135.9, 123.6, 120.7, 81.3, 75.9, 63.3, 48.7, 44.8, 18.0, 16.5, 
15.0, 12.0, −1.4; IR (film): υ~  = 3337, 2966, 2887, 1694, 1519, 
1466, 1394, 1248, 1171, 1060, 945, 856, 835, 776, 693 cm-1; HRMS (ESI): m/z: calcd for 
C18H32NO3SiI+Na: 488.108836 [M++Na]; found: 488.108256; elemental analysis calcd (%) for 




Compound 53. A solution of TBAF (0.5 mL, 1 M in THF) was added dropwise to a solution of 
compound 62 (128 mg, 0.275 mmol) in THF (6 mL) at 0°C. The mixture was stirred overnight at 
ambient temperature before a second batch of TBAF (0.5 mL, 1 M in THF) was introduced. After 
additional 8 h, the mixture was diluted with EtOAc and extracted with aq. sat. Na2CO3, and the 
organic layers were washed with brine, dried over Na2SO4, and evaporated.  
The resulting free amine 63 was dissolved in CH2Cl2 (5 mL). 
57 (75 mg, 0.3 mmol), HOBt (40 mg, 0.3 mmol), and N-
methylmorpholine (NMM, 0.088 mL, 0.8 mmol) were 
successively added and the mixture was cooled to 0°C. 
EDC.HCl (68 mg, 0.35 mmol) was then introduced and the 
mixture stirred at ambient temperature for 20 h. After 
dilution with EtOAc and extraction with brine, the combined 
organic layers were dried over Na2SO4 and evaporated, and the residue was purified by flash 
chromatography (hexanes/EtOAc 1:1) to give product 53 as a white solid (121 mg, 80%). [ ]20Dα = 
+29.3 (c = 1.0, CH2Cl2); 1H NMR (400 MHz, CD2Cl2): δ = 8.22 (s, 1H), 6.63-6.48 (m, 3H), 6.20-
6.10 (m, 3H), 4.47-4.40 (m, 1H), 4.04 (dd, J = 9.8, 4.0 Hz, 1H), 3.98-3.81 (m, 2H), 3.78 (d, J = 
7.9 Hz, 1H), 3.62 (dt, J = 8.8, 1.9 Hz, 1H), 2.44-2.35 (m, 1H), 1.74 (s, 3H), 1.71 (s, 3H), 0.90-
0.85 (m, 12H), 0.10 (s, 3H). 0.08 (s, 3H); 13C NMR (100 MHz, CD2Cl2): δ = 170.2, 161.6, 149.6, 
138.5, 135.3, 123.5, 122.3, 81.7, 76.4, 63.5, 53.4, 47.8, 45.2, 26.3, 18.8, 16.8, 15.5, 12.4, −5.0; IR 
(film): υ~  = 3302, 2928, 2857, 1650, 1530, 1385, 1255, 1107, 953, 834, 710) cm-1; HRMS (ESI): 









Compound 64. Ba(OH)2.8H2O (50 mg, 0.158 mmol) and (dppf)PdCl2 (12 mg, 0.016 mmol) were 
added to a degassed solution containing 
compounds 62 (50 mg, 0.107 mmol) and 
19 (37 mg, 0.127 mmol) in DMF (2.5 mL). 
The mixture was stirred for 2 h at ambient 
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EtOAc and extracted with brine. The combined organic layers were dried over Na2SO4 and 
evaporated, and the residue was purified by flash chromatography (hexanes/EtOAc, 4:1) to give 
product 64 as a colorless syrup (39 mg, 70%). [ ]20Dα = +26.6 (c = 0.78, CH2Cl2); 1H NMR (400 
MHz, C lD2C 2): δ = 6.78 (ddd, J = 17.3, 10.8, 0.8 Hz, 1H), 6.18 (m, 4H), 5.64 (m, 1H), 5.45 (m, 
1H), 5.38 (m, 1H), 5.19 (dd, J = 17.3, 0.8 Hz, 1H), 5.07 (m, 1H), 4.79 (bs, 1H), 4.15 (t, J = 8.4 
Hz, 2H), 3.75 (m, 3H), 3.52 (m, 1H), 3.21 (s, 3H), 2.38 (m, 1H), 2.20 (m, 2H), 1.81 (s, 3H), 1.75 
(s, 3H), 1.73 (s, 3H), 1.63 (m, 1H), 1.49 (m, 1H), 0.98 (t, J = 8.4 Hz, 2H), 0.90 (d, J = 6.7 Hz, 
3H), 0.04 (s, 9H); 13C NMR (100 MHz, CD2Cl2): δ = 157.0, 138.1, 136.9, 135.6, 134.1, 133.2, 
133.0, 132.8, 131.4, 131.0, 123.2, 121.0, 113.4, 82.1, 81.6, 63.3, 56.3, 48.8, 41.6, 36.0, 23.6, 
19.9, 18.1, 17.3, 15.0, 11.9, −1.4; IR (film): υ~  = 3457, 2925, 2855, 1737, 1516, 1448, 1366, 
29, 1216, 1099, 1060, 989, 858, 836, 776, 694 cm12 -1; HRMS (ESI): m/z: calcd for 
C29H49NO4Si+Na: 526.332305 [M++Na]; found: 526.332366; elemental analysis calcd (%) for 
C29H49NO4Si: C 69.14, H 9.80; found: C 68.96, H 9.72. 
Compound 65. EDC·HCl (14.5 mg, 0.0756 mmol) and 4-pyrrolidino-pyridine (14.5 mg, 0.0983 
mmol) were added to a solution of 
compounds 47 (20 mg, 0.0756 mmol) 
and 64 (19 mg, 0.0377 mmol) in 
CH2Cl2 (1.0 mL) at 0ºC. The mixture 
was warmed to ambient temperature 
and stirred for 48 h. It was then cooled 
again to 0°C before additional 
EDC·HCl (2.2 mg, 0.0115 mmol) and 4-pyrrolidino-pyridine (1.7 mg, 0.0115 mmol) were 
introduced. After another 48 h at ambient temperature, the mixture was diluted with EtOAc, 
filtered through a pad of Celite, the filtrate was adsorbed on silica and submitted to flash 
chromatography (hexanes/EtOAc, 20:1→2:1) to furnish product 65 as a colorless oil (22 mg, 
78%). = +17.0 (c = 0.20, CH[ ]20Dα 2Cl2); 1H NMR (400 MHz, CD2Cl2): δ = 6.73 (dd, J = 17.3, 
10.8 Hz, 1H), 6.53 (dd, J = 9.7, 1.3 Hz, 1H), 6.21 (d, J = 11.2 Hz, 1H), 6.11-6.02 (m, 4H), 5.74 
(ddt, J = 17.3, 10.2, 7.0 Hz, 1H), 5.58-5.52 (m, 2H), 5.38-5.33 (m, 2H), 5.21(d, J = 9.1 Hz, 1H), 
5.15 (d, J = 17.4 Hz, 1H), 5.09-4.91 (m, 4H), 4.74 (brs, 1H), 4.11 (dd, J = 8.3, 8.3 Hz, 2H), 4.00 
(dt, J = 9.0, 6.4 Hz, 1H), 3.72 (d, J = 5.9 Hz, 2H), 3.45 (q, J = 7.3 Hz, 1H), 3.25-3.17 (m, 1H), 
3.17 (s, 3H), 3.13 (s, 3H), 2.64-2.54 (m, 1H), 2.29 (m, 1H), 2.20-2.12 (m, 3H), 1.80 (d, J = 1.4 
Hz, 3H), 1.76 (d, J = 1.3 Hz, 3H), 1.73 (d, J = 1.0 Hz, 3H), 1.71 (s, 6H), 1.62-1.55 (m, 1H), 1.47-
1.39 (m, 1H), 1.10 (d, J = 6.7 Hz, 3H), 0.99-0.96 (m, 2H), 0.93 (d, J = 6.8 Hz, 3H), -0.02 (s, 9H); 
13C NMR (150 MHz, CD2Cl2): δ = 168.9, 158.4, 146.5, 138.3, 137.7, 136.6, 135.9, 135.6, 135.1, 
134.4, 134.1, 133.4, 133.3, 132.4, 132.1, 128.6, 125.8, 122.1, 118.2, 114.9, 84.5, 83.0, 78.6, 64.7, 
57.6, 57.5, 50.2, 41.8, 41.3, 38.1, 37.4, 25.0, 21.9, 21.3, 19.5, 18.5, 16.5, 14.6, 14.2, 14.1, 0.0; IR 
(film): υ~  = 3336, 2924, 1712, 1519, 1448, 1249, 1098, 991, 966, 859, 834 cm-1; HRMS (ESI): 
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Compound 66. Complex 50 (1 mg, 0.0012 mmol) was added to a solution of compound 65 (9.0 
mg, 0.0116 mmol) in CH2Cl2 (20 mL) and the mixture was stirred at ambient temperature. After 
24 h, a second portion of complex 50 (0.5 mg, 0.0006 mmol) was introduced and stirring 
continued for 48 h before the reaction was 
quenched with ethyl vinyl ether (50 μL). 
After stirring for 1 h, all volatile materials 
were evaporated and the residue purified 
by flash chromatography 
(hexanes/EtOAc, 12:1→8:1) to give 
product 66 as a pale brown solid (6.5 mg, 78%). [ ]20Dα = +5.0 (c = 0.10, CH2Cl2); 1H NMR (400 
MHz, CD2Cl2): δ = 6.57 (dd, J = 10.3, 1.4 Hz, 1H), 6.46 (d, J = 15.7 Hz, 1H), 6.29 (d, J = 11.2 
Hz, 1H), 6.12 (dq, J = 11.2, 1.2 Hz, 1H), 6.04 (dd, J = 14.3, 10.5 Hz, 1H), 5.97 (dd, J = 14.5, 10.5 
Hz, 1H), 5.89 (d, J = 15.5 Hz, 1H), 5.52 (ddd, J = 15.5, 9.7, 4.6 Hz, 1H), 5.48 (dd, J = 15.5, 9.0 
Hz, 1H), 5.38 (dd, J = 14.1, 7.9 Hz, 1H), 5.36 (dd, J = 14.5, 9.7 Hz, 1H), 5.18 (dd, J = 10.5, 5.8 
Hz, 1H), 5.09 (d, J = 10.1 Hz, 1H), 5.08 (d, J = 9.5 Hz, 1H), 4.76 (brs, 1H), 4.14 (dd, J = 8.5, 8.3 
Hz, 2H), 4.16-4.09 (m, 1H), 3.76 (d, J = 6.0 Hz, 2H), 3.29-3.23 (m, 1H), 3.21 (s, 3H), 3.18-3.12 
(m, 1H), 2.95 (s, 3H), 2.65-2.61 (m, 1H), 2.58-2.48 (m, 2H), 2.29 (dt, J = 13.5, 10.1 Hz, 1H), 
1.90-1.86 (m, 1H), 1.78 (s, 3H), 1.77 (s, 3H), 1.77 (s, 3H), 1.76 (s, 3H), 1.74 (d, J = 1.0 Hz, 3H), 
1.63-1.56 (m, 1H), 1.33-1.25 (m, 1H), 1.03 (d, J = 6.7 Hz, 3H), 0.98 (dd, J = 8.5, 8.4 Hz, 2H), 
0.91 (d, J = 6.7 Hz, 3H); 13C NMR (150 MHz, CD2Cl2): δ = 167.6, 157.0, 145.6, 137.1, 136.9, 
136.2, 133.9, 133.8, 133.7, 133.3, 132.4, 132.3, 132.1, 131.2, 129.8, 128.8, 126.0, 125.6, 125.4, 
120.6, 83.3, 79.9, 77.0, 63.3, 56.5, 55.9, 48.8, 41.0, 38.3, 35.3, 23.2, 21.5, 20.8, 18.1, 16.8, 15.1, 
13.2, 12.1, 12.1, −1.4; IR (film): υ~  = 2927, 1712, 1514, 1455, 1251, 1100, 989, 965, 836 cm-1; 
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Compound 68. A solution of TBAF (17 μL, 1 M in THF) was added dropwise to a solution of 
compound 66 (3.0 mg, 0.0042 mmol) in THF (0.1 mL) at 0°C. The mixture was allowed to reach 
ambient temperature and was stirred for 36 h before it was diluted with EtOAc and extracted with 
aq. sat. NH4Cl. The combined organic phases were dried over MgSO4 and evaporated to give 
amine 67 which was immediately used in the next step without further purification. 
N-Formyl-L-valine (0.8 mg, 0.0054 
mmol), HOAt (0.70 mg, 0.0050 
mmol), and collidine (1.7 μL, 0.013 
mmol) were added to a solution of 
crude 67 in CH2Cl2 (0.1 mL) and the 
solution was cooled to 0°C before 
EDC.HCl (1.2 mg, 0.0063 mmol) was 
introduced. The mixture was stirred at ambient temperature for 20 h. A standard extractive work 
up followed by flash chromatography of the crude material (hexanes/EtOAc, 5:1→1:2) afforded 
product 68 (3 mg, 100%) contaminated with ca. 10% isomeric impurities. An analytically pure 




2Cl2); 1H NMR (600 MHz, C6D6): δ = 7.68 (s, 1H), 7.01 (d, J = 11.4 Hz, 1H), 6.81 (d, J 
= 15.6 Hz, 1H), 6.48 (d, J = 11.2 Hz, 1H), 6.11 (d, J = 11.2 Hz, 1H), 6.01 (dd, J = 15.0, 10.5 Hz, 
1H), 5.79 (d, J = 15.7 Hz, 1H), 5.75 (dd, J = 15.2, 10.5 Hz, 1H), 5.60-5.57 (m, 1H), 5.54 (d, J = 
10.2 Hz, 1H), 5.48-5.43 (m, 2H), 5.35 (dd, J = 15.2, 9.5 Hz, 1H), 5.27-5.23 (m, 2H), 5.20-5.15 
(m, 2H), 4.16 (dd, J = 7.9, 7.9 Hz, 1H), 3.98 (td, J = 9.5, 1.6 Hz, 1H), 3.74 (dd, J = 15.5, 6.3 Hz, 
1H), 3.54 (dd, J = 15.5, 5.6 Hz, 1H), 3.39-3.36 (m, 1H), 3.14 (s, 3H), 3.13 (s, 3H), 2.99-2.88 (m, 
2H), 2.86-2.80 (m, 1H), 2.56-2.48 (m, 2H), 1.94 (s, 3H), 1.90-1.86 (m, 2H), 1.84 (s, 3H), 1.82 (s, 
3H), 1.79-1.71 (m, 1H), 1.49 (s, 6H), 1.36-1.17 (m, 1H), 0.88-0.85 (m, 9H), 0.78 (d, J = 6.8 Hz, 
3H); 13C NMR (150 MHz, C6D6): δ = 170.4, 167.1, 160.4, 145.9, 136.9, 136.0, 135.9, 133.9, 
133.7, 133.3, 133.1, 132.5, 131.8, 131.7, 130.0, 129.2, 126.0, 125.9, 125.5, 121.1, 83.1, 79.5, 
76.9, 57.2, 56.4, 55.5, 46.7, 41.6, 41.4, 38.5, 35.3, 31.3, 23.3, 21.3, 21.2, 19.5, 18.1, 16.9, 14.9, 
13.0, 12.2, 12.1; IR (film): υ~  = 3287, 2959, 2924, 2854, 1651 (br), 1547, 1461, 1377, 1259, 
1217, 1102, 965, 801, 744 cm-1; HRMS (ESI): m/z: calcd for C43H64N2O6+Na: 727.4663 












Compound 69b. Amine 67 was 
prepared as described above 
from compound 66 (8 mg, 
0.0113 mmol) and TBAF (45 μL, 
1M in THF). N-Benzoyl-O-TBS-
L-serine (7.5 mg, 0.023 mmol), 
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NMM (4 μL, 0.036 mmol) were added to a solution of crude amine 67 in CH2Cl2 (1.5 ml) and the 
mixture was cooled to 0°C before EDC.HCl (4 mg, 0.02 mmol) was introduced. After stirring for 
20 h at ambient temperature, the mixture was adsorbed on silica and the product purified by flash 
chromatography (hexanes/EtOAc, 2:1), furnishing product 69b (3 mg, 31%) that contained ca. 5-
10% of isomeric impurities. [ ]20Dα = −7 (c = 0.15, CH2Cl2); 1H NMR (400 MHz, CD2Cl2): δ = 
7.81 (m, 2H), 7.54 (m, 1H), 7.46 (m, 2H), 7.14 (d, J = 5.7 Hz, 1H), 6.63 (m, 1H), 6.57 (d, J = 
10.2 Hz, 1H), 6.46 (d, J = 15.5 Hz, 1H), 6.28 (d, J = 11.4 Hz, 1H), 6.16 (d, J = 11.4 Hz, 1H), 
6.09-5.85 (m, 3H), 5.56-5.43 (m, 2H), 5.42-5.34 (m, 2H), 5.18 (m, 1H), 5.08 (m, 2H), 4.54 (m, 
1H), 4.20-4.05 (m, 2H), 4.00-3.82 (m, 2H), 3.71 (m, 1H), 3.29-3.21 (m, 1H), 3.20 (s, 3H), 3.18-
3.10 (m, 1H), 2.95 (s, 3H), 2.67-2.47 (m, 3H), 2.30 (m, 1H), 1.87 (m, 1H), 1.77 (bs, 12H), 1.75 
(s, 3H), 1.67-1.51 (m, 1H), 1.33-1.24 (m, 1H), 1.03 (d, J = 6.7 Hz, 3H), 0.90 (m, 12H), 0.14 (s, 
3H), 0.11 (s, 3H); 13C NMR (100 MHz, CD2Cl2): δ = 170.4, 167.5, 167.2, 145.6, 137.1, 135.9, 
134.3, 134.2, 134.1, 133.8, 133.7, 133.3, 132.4, 132.3, 132.1 (2x), 132.0, 131.2, 129.8, 128.9, 
128.8, 127.3, 125.5, 125.4, 121.6, 83.3, 79.8, 77.0, 63.2, 56.5, 55.9, 55.0, 47.4, 41.0 (2x), 38.3, 
35.3, 25.9, 23.2, 21.5, 20.8, 18.4, 16.8, 15.2, 13.1, 12.1, 12.0, −5.4, −5.5; IR (film): υ~  = 3298, 
2925, 2856, 1711, 1640, 1535, 1463, 1258, 1215, 1100, 988, 963, 836, 778, 692 cm-1; HRMS 
(ESI): m/z: calcd for C53H78N2O7Si+Na: 905.547050 [M++Na]; found: 905.547729. 
Compound 69. A solution of TBAF (4 μL, 1 M in THF) was added to a solution of compound 
69b (3 mg, 0.0034 mmol) in THF 
(0.2 mL) at 0°C and stirring was 
continued at that temperature for 
20 min. The mixture was 
adsorbed on silica and the 
product purified by flash 
chromatography (hexanes/ 
EtOAc, 1:1) to give compound 
69 (1.5 mg, 57%) which contained ~10% of isomeric impurities. An analytically pure sample was 
obtained by preparative HPLC. [ ] = +4 (c = 0.16, CH20Dα 2Cl2); 1H NMR (600 MHz, CD2Cl2): δ = 
7.82 (m, 2H), 7.55 (m, 1H), 7.47 (m, 2H), 7.27 (d, J = 6.6 Hz, 1H), 6.92 (t, J = 5.6 Hz, 1H), 6.57 
(m, 1H), 6.45 (d, J = 15.2 Hz, 1H), 6.27 (d, J = 10.9 Hz, 1H), 6.13 (m, 1H), 6.06-5.94 (m, 2H), 
5.89 (d, J = 15.2 Hz, 1H), 5.55-5.45 (m, 2H), 5.40-5.34 (m, 2H), 5.18 (m, 1H), 5.08 (m, 2H), 4.60 
(m, 1H), 4.23 (m, 1H), 4.11 (dt, J = 9.9, 2.2 Hz, 1H), 3.95-3.83 (m, 2H), 3.74 (m, 1H), 3.27 (m, 
1H), 3.21 (s, 3H), 3.20 (m, 1H), 3.15 (m, 1H), 2.95 (s, 3H), 2.63 (m, 1H), 2.55-2.47 (m, 2H), 2.29 
(m, 1H), 1.88 (m, 1H), 1.77 (s, 3H), 1.76 (s, 3H), 1.75 (s, 3H), 1.74 (s, 3H), 1.70 (s, 3H), 1.61-
1.54 (m, 1H), 1.33-1.25 (m, 1H), 1.04 (d, J = 6.8 Hz, 3H), 0.90 (d, J = 6.8 Hz, 3H); 13C NMR 
(125 MHz, CD2Cl2): δ = 171.3, 168.2, 167.5, 145.6, 137.1, 136.1, 135.6, 134.2, 133.8, 133.7, 
133.7, 133.3, 132.4 (2x), 132.3, 132.1, 131.2, 129.8, 129.0, 128.8, 127.5, 126.0, 125.4, 125.3, 
121.0, 83.1, 80.0, 77.1, 63.1, 56.5, 55.9, 55.4, 47.0, 41.0, 40.8, 38.2, 35.3, 23.2, 21.5, 20.8, 16.8, 
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989, 964, 744, 712 cm-1; HRMS (ESI): m/z: calcd for C47H64N2O7+Na: 791.460572 [M++Na]; 
found: 791.460821. 
Compound 70. Et3N (0.4 µL, 0.0031 mmol) and dansyl chloride (0.8 mg, 0.0029 mmol) were 
sequentially added to a 
solution of crude amine 67 
[prepared from 66 (2 mg) as 
described above] in CH2Cl2 
(0.03 mL) at 0ºC. After 
stirring for 6 h, the mixture 
was adsorbed on silica and the product purified by flash chromatography (hexanes/EtOAc, 
20:1→5:1) to give product 70 as a white solid (1 mg, 45% over 2 steps). = +4 (c = 0.1, 
CH
[ ]20Dα
2Cl2); 1H NMR (600 MHz, CD2Cl2): δ = 8.54 (d, J = 8.6 Hz, 1H), 8.26 (d, J = 8.6 Hz, 1H), 
8.20 (dd, J = 7.4, 1.0 Hz, 1H), 7.58 (dd, J = 8.4, 7.8 Hz, 1H), 7.52 (dd, J = 8.4, 7.4 Hz, 1H), 7.21 
(d, J = 7.4 Hz, 1H), 6.56 (dd, J = 10.2, 1.3 Hz, 1H), 6.46 (d, J = 15.8 Hz, 1H), 6.10 (d, J = 10.5 
Hz, 1H), 6.04-5.93 (m, 3H), 5.89 (d, J = 15.4 Hz, 1H), 5.54-5.45 (m, 2H), 5.39-5.37 (m, 2H), 
5.08 (d, J = 9.4 Hz, 1H), 5.01 (d, J = 10.2 Hz, 1H), 4.77 (t, J = 6.2 Hz, 1H), 4.10 (td, J = 10.0, 2.9 
Hz, 1H), 3.51 (d, J = 6.1 Hz, 2H), 3.27-3.23 (m,1H), 3.21 (s, 3H), 3.18-3.15 (m, 1H), 2.94 (s, 
3H), 2.88 (s, 6H), 2.64-2.61 (m, 1H), 2.56-2.47 (m, 2H), 2.29 (dt, J = 10.4, 9.5 Hz, 1H), 1.89-
1.83 (m, 1H), 1.77 (s, 6H), 1.75 (d, J = 1.3 Hz, 3H), 1.63 (s, 3H), 1.61-1.52 (m, 1H), 1.34-1.28 
(m, 1H), 1.04 (d, J = 6.7 Hz, 3H), 0.86 (d, J = 6.8 Hz, 3H); IR (film): υ~  = 3346, 2926, 1712, 
1652, 1614, 1553, 1446, 1389, 1262, 1212, 1147, 1098, 990, 967 cm-1; HRMS (ESI): m/z: calcd 
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Total Synthesis of Iejimalide A 
 
Compound 76. Compounds 36 (335 mg, 0.807 mmol) and 7515 (332 mg, 0.74 mmol), CuTC 
(200 mg, 1.05 mmol) and Pd(PPh3)4 (51 mg, 0.0044 mmol) were 
successively added to thoroughly dried Ph2PO2NBu4 (475 mg, 
1.034 mmol) in degassed DMF (12 mL). The resulting brown 
mixture was stirred for 1 h before it was diluted with H2O and 
EtOAc. The mixture was filtered through a pad of Celite, the filtrate 
was diluted with EtOAc and washed with brine, the organic layer was dried over Na2SO4 and 
evaporated, and the residue purified by flash chromatography (hexanes/EtOAc, 20:1) to give the 
silyl ether 76b (R = TBDPS) as a colorless oil (271 mg, 82%). [ ]20Dα = −18.5 (c = 1.05, CH2Cl2); 
1H NMR (400 MHz, CD2Cl2): δ = 7.67 (m, 4H), 7.40 (m, 6H), 6.13 (d, J = 15.7 Hz, 1H), 5.78 (m, 
1H), 5.65 (dd, J = 15.7, 7.5 Hz, 1H), 5.23 (d, J = 8.8 Hz, 1H), 5.08-4.98 (m, 2H), 4.05 (m, 1H), 
3.56 (m, 2H), 3.21 (s, 3H), 2.48 (m, 1H), 2.35 (m, 1H), 2.21 (m, 1H), 1.77 (d, J = 1.2 Hz, 3H), 
1.07 (d, J = 6.8 Hz, 3H), 1.05 (s, 9H); 13C NMR (100 MHz, CD2Cl2): δ = 137.2, 136.0, 135.3, 
134.4, 134.3, 132.6, 131.2, 129.9, 128.0, 116.7, 77.2, 69.1, 56.0, 40.5, 39.9, 27.0, 19.5, 16.9, 
13.2; IR (film): υ~  = 2958, 2931, 2858, 1472, 1428, 1389, 1188, 1103, 965, 965, 914, 823, 739, 
701 cm-1; HRMS (ESI): m/z: calcd for C29H40O2Si+Na: 471.268976 [M++Na]; found: 
471.269022; elemental analysis calcd (%) for C29H40O2Si: C 77.62, H 8.99; found: C 77.68, H 
9.06. 
ORMeO
A solution of TBAF (0.4 mL, 1 M in THF) was added to a solution of compound 76b (114 mg, 
0.254 mmol) in THF (6 mL) at 0°C and the mixture was stirred at ambient temperature for 16 h. 
A standard extractive work up followed by flash chromatography of the crude product 




2Cl2); 1H NMR (300 MHz, CD2Cl2): δ = 6.18 (d, J = 15.8 Hz, 1H), 5.79 (m, 1H), 5.56 
(dd, J = 15.8, 7.8 Hz, 1H), 5.27 (d, J = 9.0 Hz, 1H), 5.03 (m, 2H), 4.05 (m, 1H), 3.45 (m, 2H), 
3.20 (s, 3H), 2.30 (m, 2H), 2.22 (m, 1H), 1.79 (s, 3H), 1.65 (bs, 1H), 1.03 (d, J = 6.8 Hz, 3H); 13C 
NMR (75 MHz, CD2Cl2): δ = 136.9, 135.2, 135.1, 132.1, 131.7, 116.8, 77.1, 67.7, 56.2, 40.4 
(2x), 16.8, 13.2; IR (film): υ~  = 3403, 2974, 2926, 1641, 1450, 1383, 1241, 1189, 1079, 1037, 
964, 914, 816 cm-1; HRMS (ESI): m/z: calcd for C13H22O2+Na: 233.151197 [M++Na]; found: 
233.151456; elemental analysis calcd (%) for C13H22O2: C 74.24, H 10.54; found: C 74.20, H 
10.42. 
Compound 84. 4-Pyrrolidinylpyridine (1.4 mg, 0.0095 mmol) and DCC (13.3 mg, 0.0646 mmol) 
were added to a solution of (EtO)2P(O)CH2COOH (10.4 μL, 0.0646 mmol) in CH2Cl2 (0.15 mL) 
at 0°C. After stirring for 10 min at ambient temperature, the resulting suspension was cooled to 
0°C before a solution of compound 54 (38 mg, 0.0646 mmol) in CH2Cl2 (0.2 mL) was 
                                                   
15  Prepared as described for the other enantiomer in: Paquette, L. A.; Guevel, R.; Sakamoto, S.; Kim, I. 
H.; Crawford, J. J. Org. Chem. 2003, 68, 6096. 
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introduced. The mixture was warmed to ambient temperature within 1 h and stirred for 48 h. 
After this time, the mixture was again cooled to 0°C before more (EtO)2P(O)CH2COOH (10.4 
μL, 0.0646 mmol), 4-pyrrolidinyl-pyridine (1.4 mg, 0.0095 mmol), and DCC (13.3 mg, 0.0646 
mmol) were introduced. After stirring for another 48 h, a standard extractive work up followed by 
purification of the crude material by flash chromatography (hexanes/EtOAc, 4:1) gave product 84 
as a colorless oil (41 mg, 82%). [ ] = +23.6 (c = 0.42, CH20Dα 2Cl2); 1H NMR (400 MHz, CD2Cl2): 
δ = 8.23 (s, 1H), 6.76 (dd, J = 17.3, 
10.8 Hz, 1H), 6.53 (m, 2H), 6.23 (d, J 
= 11.2 Hz, 1H), 6.11 (m, 3H), 5.65 
(dd, J = 14.5, 7.8 Hz, 1H), 5.43 (m, 
1H), 5.37 (m, 1H), 5.19 (d, J = 17.3 
Hz, 1H), 5.07 (d, J = 10.8 Hz, 1H), 
5.01 (d, J = 8.3 Hz, 1H), 4.43 (m, 
1H), 4.07 (m, 5H), 3.88 (m, 2H), 3.62 (m, 1H), 3.50 (m, 1H), 3.19 (s, 3H), 2.89 (m, 2H), 2.59 (m, 
1H), 2.19 (m, 2H), 1.80 (s, 3H), 1.75 (s, 6H), 1.62 (m, 1H), 1.48 (m, 1H), 1.29 (t, J = 6.9 Hz, 
6H), 0.95 (d, J = 6.9 Hz, 3H), 0.89 (s, 9H), 0.10 (s, 3H), 0.09 (s, 3H); 13C NMR (100 MHz, 
CD2Cl2): δ = 169.8, 165.3, 161.2, 135.9, 135.8, 134.2, 134.1, 133.0 (2x), 132.9, 131.0, 130.7, 
124.8, 121.7, 113.5, 84.5, 81.6, 63.1, 62.8, 56.2, 53.5, 47.4, 39.4, 36.0, 34.0, 25.9, 23.6, 19.8, 
18.4, 16.9, 16.6, 16.5, 15.2, 12.6, −5.4, −5.5; IR (film): υ~  = 3291, 2928, 2857, 1733, 1656, 1532, 
1463, 1388, 1255, 1100, 1050, 1022, 972, 835, 777 cm-1; HRMS (ESI): m/z: calcd for 
C39H67N2O9PSi+Na: 789.424569 [M++Na]; found: 789.423875; elemental analysis calcd (%) for 











Compound 85. Method A: Hünig base (3.8 μL, 0.021 mmol) was added to a mixture of 
compound 84 (15 mg, 0.0195 
mmol) and LiCl (1.7 mg, 0.04 
mmol) in MeCN (0.7 mL) at 0°C. 
After stirring at ambient 
temperature for 15 min, the 
mixture was again cooled to 0°C 
before a solution of crude 
aldehyde 77 [freshly prepared in situ upon oxidation of 76 (8 mg, 0.038 mmol)]16 in MeCN (0.4 
mL) was added dropwise. After stirring at ambient temperature for 16 h, the mixture was diluted 











                                                   
16  Dess-Martin periodinane (20 mg, 0.047 mmol) was added to a solution of compound 76 (8 mg, 0.038 
mmol) in CH2Cl2 (2 mL) and the mixture stirred at ambient temperature for 30 min. After dilution 
with hexane and aq. sat. NaHCO3, the suspension was filtered through a pad of Celite and extracted 
with aq. sat. NaHCO3, aq. sat. Na2S2O3 and brine. Drying of the organic phase over MgSO4 and 
evaporation of the solvent gave crude 77 which was immediately used in the next step because it is 
very unstable even upon storage at low temperature. 
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and the residue purified by flash chromatography (hexanes/EtOAc, 1:1) to give product 85 (5 mg, 
31%, ≥ 85% pure) and recovered 84 (8 mg, 47% conversion).  
Method B: Hünig base (2.2 μL, 0.012 mmol) was added to a mixture of compound 84 (9 mg, 
0.0117 mmol) and LiCl (1 mg, 0.023 mmol) in MeCN (0.3 mL) at 0°C. After stirring at ambient 
temperature for 15 min, the mixture was again cooled to 0°C before a solution of crude 77 
[freshly prepared upon oxidation of 76 (3.5 mg, 0.0167 mmol)] in MeCN (0.1 mL) was slowly 
introduced. After stirring at ambient temperature for 20 h, the mixture was again cooled to 0°C 
and another batch of 77 [freshly prepared from 2 mg of 76 (0.0095 mmol)] was added. Stirring 
was continued for another 16 h before a standard extractive work up and flash chromatography of 
the crude material (hexanes/EtOAc, 1:1) gave product 85 (3.5 mg, 36%, ≥ 85% pure) and 
recovered 84 (4 mg, 55% conversion). [ ]20Dα = +16.4 (c = 0.35, CH2Cl2); 1H NMR (400 MHz, 
CD2Cl2): δ = 8.23 (s, 1H), 6.89 (dd, J = 15.7, 6.8 Hz, 1H), 6.77 (dd, J = 17.3, 10.8 Hz, 1H), 6.51 
(m, 2H), 6.22 (d, J = 11.3 Hz, 1H), 6.17-6.05 (m, 4H), 5.79 (m, 2H), 5.60 (m, 2H), 5.38 (m, 2H), 
5.27 (d, J = 8.8 Hz, 1H), 5.19 (d, J = 17.3 Hz, 1H), 5.11-4.98 (m, 4H), 4.42 (m, 1H), 4.05 (m, 
2H), 3.87 (m, 2H), 3.62 (m, 1H), 3.50 (m, 1H), 3.21 (s, 3H), 3.18 (s, 3H), 3.08 (m, 1H), 2.60 (m, 
1H), 2.35 (m, 1H), 2.27-2.13 (m, 3H), 1.80 (s, 3H), 1.78 (s, 3H), 1.74 (s, 6H), 1.63 (m, 1H), 1.47 
(m, 1H), 1.18 (d, J = 6.7 Hz, 3H), 0.95 (d, J = 6.9 Hz, 3H), 0.88 (s, 9H), 0.10 (s, 3H), 0.08 (s, 
3H); 13C NMR (100 MHz, CD2Cl2): δ = 169.8, 166.0, 161.1, 152.5, 136.7, 136.3, 135.4, 135.2, 
134.8, 134.7, 134.2, 133.1, 133.0, 132.8, 132.3, 131.2, 131.0, 130.6, 124.4, 121.8, 120.3, 116.8, 
113.5, 82.9, 81.6, 77.2, 63.1, 56.2, 56.1, 53.4, 47.5, 40.4, 39.8, 39.7, 36.0, 25.9, 23.6, 19.8, 17.0, 
15.2, 16.5, 15.2, 13.2, 12.8, −5.4, −5.5; IR (film): υ~  = 3295, 2926, 2856, 1717, 1651, 1539, 
1463, 1380, 1257, 1171, 1098, 988, 836, 778 cm-1; HRMS (ESI): m/z: calcd for 
C48H76N2O7Si+Na: 843.531401 [M++Na]; found: 843.530737. 
Compound 86. Complex 50 (1 mg, 0.0012 mmol) was added to a solution of compound 85 (9.5 
mg, 0.0115 mmol, ca. 85% pure) in 
CH2Cl2 (18 mL) and the resulting 
mixture was stirred at ambient 
temperature for 24 h before a 
second portion of catalyst 50 (0.5 
mg, 0.0006 mmol) was introduced 
and stirring was continued for 
another 48 h. The reaction was quenched with ethyl vinyl ether (50 μL) and stirred for 15 min. 
Evaporation of the solvent followed by flash chromatography (hexanes/EtOAc, 1:1) gave product 
86 as a mixture of isomers (5 mg, 55%, ≥ 80% pure). Purification by preparative HPLC gave 86 
in ≥ 90% purity. = −18 (c = 0.13, CH[ ]20Dα 2Cl2); 1H NMR (600 MHz, MeOD): δ = 8.14 (s, 1H), 
6.85 (dd, J = 15.4, 9.3 Hz, 1H), 6.47 (d, J = 15.4 Hz, 1H), 6.32 (d, J = 10.8 Hz, 1H), 6.22 (d, J = 
10.8 Hz, 1H), 6.10 (dd, J = 15.0, 10.3 Hz, 1H), 6.01 (m, 2H), 5.77 (d, J = 15.4 Hz, 1H), 5.61-5.52 
(m, 2H), 5.48 (dd, J = 14.8, 8.9 Hz, 1H), 5.40 (dd, J = 15.0, 8.3 Hz, 1H), 5.24 (m, 1H), 5.13 (m, 
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3H), 3.05 (m, 1H), 2.67-2.54 (m, 2H), 2.44 (m, 1H), 2.32 (m, 1H), 1.97 (m, 1H), 1.81 (s, 6H), 
1.79 (s, 6H), 1.60 (m, 1H), 1.38 (m, 1H), 1.13 (d, J = 6.7 Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H), 0.91 
(s, 9H), 0.09 (s, 6H); 13C NMR (150 MHz, MeOD): δ = 171.8, 167.8, 163.8, 154.1, 138.3, 136.9, 
136.7, 135.2, 134.4, 134.1, 133.6, 133.5, 132.9, 132.5, 131.9, 130.7, 129.3, 126.6, 126.0, 121.9, 
120.2, 84.5, 81.5, 78.1, 64.4, 56.9, 56.1, 55.4, 47.8, 42.9, 41.3, 41.1, 36.1, 26.3, 23.9, 22.1, 20.9, 
19.1, 17.2, 15.3, 13.4, 12.3, −5.4; IR (film): υ~  = 2926, 2857, 1717, 1648, 1455, 1377, 1347, 
1259, 1221, 1106, 987, 836, 779 cm-1; HRMS (ESI): m/z: calcd for C46H72N2O7Si+Na: 
815.500098 [M++Na]; found: 815.499381. 
Iejimalide A (1). A solution of TBAF (4.4 μL, 1 M in THF) was added to a solution of 
compound 86 (3.5 mg, 0.0044 mmol) 
in THF (0.2 mL) at 0°C. After stirring 
for 10 min at this temperature, the 
mixture was adsorbed on silica and 
the product purified by flash 
chromatography (hexanes/EtOAc, 
1:1) to give iejimalide A (2 mg, 67%, 
≥ 80% pure). An analytically pure sample of 1 was obtained by preparative HPLC. The 
spectroscopic data are in full agreement with those of the natural product reported in the 
literature. [ ]20Dα = −32 (c = 0.06, CH2Cl2) (−36.4, CHCl3);14a 1H NMR (600 MHz, MeOD): δ = 
8.17 (s, 1H), 6.83 (dd, J = 15.5, 9.4 Hz, 1H), 6.45 (d, J = 15.6 Hz, 1H), 6.32 (d, J = 11.1 Hz, 1H), 
6.21 (dd, J = 11.1, 1.3 Hz, 1H), 6.07 (dd, J = 14.9, 10.3 Hz, 1H), 5.97 (m, 2H), 5.74 (d, J = 15.5, 
0.5 Hz, 1H), 5.60 (m, 1H), 5.56 (dd, J = 15.5, 8.9 Hz, 1H), 5.45 (dd, J = 15.1, 8.9 Hz, 1H), 5.38 
(dd, J = 15.1, 7.9 Hz, 1H), 5.22 (m, 1H), 5.12 (d, J = 9.5 Hz, 1H), 5.09 (d, J = 9.9 Hz, 1H), 4.50 
(t, J = 4.7 Hz, 1H), 4.23 (td, J = 9.5, 3.1 Hz, 1H), 3.89-3.77 (m, 4H), 3.38-3.34 (m, 1H), 3.25 (s, 
3H), 3.05 (s, 3H), 3.03-3.00 (m, 1H), 2.64-2.61 (m, 1H), 2.60-2.54 (m, 1H), 2.44-2.40 (m, 1H), 
2.34-2.28 (m, 1H), 1.96-1.93 (m, 1H), 1.79 (s, 3H), 1.78 (s, 3H), 1.77 (s, 3H), 1.76 (s, 3H), 1.61-
1.55 (m, 1H), 1.40-1.32 (m, 1H), 1.11 (d, J = 6.8 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H); 13C NMR 
(150 MHz, MeOD): δ = 172.1, 167.8, 163.9, 154.0, 138.3, 137.0, 136.7, 135.2, 134.2, 134.1, 
133.6, 133.5, 132.9, 132.6, 131.9, 130.7, 129.3, 126.6, 126.0, 121.2, 120.2, 84.6, 81.5, 78.1, 63.0, 
56.9, 56.1, 55.5, 47.5, 42.9, 41.3, 41.1, 36.1, 23.9, 22.0, 20.9, 17.2, 15.1, 13.4, 12.2; IR (film): υ~  
= 3367, 2924, 2853, 1716, 1658, 1468, 1260, 1108, 989, 838 cm-1; HRMS (ESI): m/z: calcd for 
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